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Alterations in T cell function and activation during exposure to the herbicide 3,4 
dichloropropionanilide (DCPA) and its metabolites 
 
Tricia L. Lewis 
 
Approximately 5.3 bi llion pounds of  pes ticides are applied annually ac ross t he United 
States and 15 of the top 25 most used pesticides are herbicides. Total herbicide use the 
in the U nited S tates r epresents 28%  of  all w orldwide her bicide us e.  DCPA ( 3,4 
dichloropropionanilide, c ommon name pr opanil) i s a pos t em ergent her bicide t hat  i s 
used extensively for control against several broadleaf plants and grasses.  I t is the 17th 
most c ommon her bicide i n t he U nited States and  6 -9 m illion pounds  are appl ied 
annually to 2 million acres of rice fields.    In mammals, DCPA is metabolized in the liver 
and pr oduces 3, 4-dichloroaniline ( DCA) and pr opionic ac id as i ts m ajor m etabolites. 
DCA is further biotransformed leading to the production of 2 hydroxylated metabolites; 
6-hydroxy-3,4-dichloroaniline (6OH-DCA) a nd N -hydroxy-3,4-dichloroaniline ( NOH-
DCA). The  i mmunomodulatory e ffects of  D CPA ar e w ell doc umented but  onl y l imited 
data i s av ailable on the ef fects of  i ts metabolites.  Previous s tudies hav e s hown t hat 
DCPA al ters t ranscription f actors i nvolved i n t he ex pression o f I L-2 and  dec reases 
mRNA and IL-2 protein in human and m ouse T c ells.  I L-2 is an early cytokine that is 
secreted by activated T c ells and plays an important role in the activation, proliferation 
and di fferentiation of  several immune cells. Expression of  IL-2 relies on activation and 
influx of calcium through channels in the plasma membrane. This study was conducted 
to examine the effects of DCPA and its metabolites on T cell activation and function and 
to propose a m echanism for the observed effects.  H uman Jurkat T c ells, a m odel cell 
line f or T cell s ignaling, w ere exposed t o i ncreasing c oncentrations of  DCPA or  its 
metabolites and T  cell function was assessed by measuring IL-2 secretion.  DCPA and 
its metabolites all inhibit IL-2 secretion in a concentration-dependent manner, however, 
NOH-DCA is the most potent inhibitor, followed by  DCPA.   To better understand the 
mechanism by  w hich t hey s uppress I L-2, N FAT ac tivity and calcium i nflux w ere 
investigated.  Interestingly, D CPA and D CA i nhibited I L-2 i n a c alcium-dependent 
manner whereas the hydroxylated metabolites inhibited IL-2 in a  calcium-independent 
manner.  The c alcium-dependent al terations i n I L-2, N FAT an d c alcium influx ar e 
influenced by  t he pr esence of  c hlorines, a s s ubstitution w ith f luorines abr ogated al l 
effects.  F urther s tudies i nvestigating t he r ole of  D CPA i n c alcium r elease-activated 
calcium (CRAC) channels revealed that activation of a key protein, Stromal interaction 
molecule-1 ( Stim1), is i nhibited by  D CPA.  C ollectively, t his dat a supports t he 
conclusion that DCPA suppresses IL-2 production by inhibiting Stim1. This mechanism 
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DCPA (chemical name 3,4-dichloropropionanilide, common name propanil) is the 
active i ngredient i n a  c ommercially av ailable her bicide di stributed under  t he s everal 
trade nam es, i ncluding C hem-Rice, H erbax and  P ropanex.  I t i s a  w idely us ed, po st-
emergent ac etanilide c ontact her bicide and i s r egistered f or us e agai nst s everal 
broadleaf and grassy weeds, such as barnyard grass, crabgrass, pigweed, foxtail and 
smartweed (USEPA 2006).  It has been registered for use as an herbicide in the United 
States ( US) s ince t he 1950s  and has  r ecently been  r equired by  t he U nited S tates 
Environmental P rotection A gency ( USEPA) t o be  r e-registered due t o i ncreased 
adverse ecological and toxicological effects (USEPA 2006). In the US, DCPA is applied 
predominantly on r ice f ields, with l esser u se on s mall gr ain a nd w heat c rops. A nnual 
use of  D CPA i s es timated t o be 6 -9 m illion pou nds per  y ear and i s di stributed on  
approximately 2 million acres of crop land (USDA 2006).  In the United States, 50-80% 
of total rice crops are treated with propanil, with major use in California, the Mississippi 
Delta and the Gulf Coast (USDA 2006).  In addition to crop use, DCPA has also recently 
been r egistered f or t urf us e on  c ommercial s od f arms (USEPA 2 006).  Thi s n ew 





Methods and rates of application 
Ground boom  s prayers and aer ial equi pment ar e t he most c ommon m eans of  
application with hand spraying also occurring in some areas.  Commercial DCPA labels 
indicate t hat handl ers s hould wear l ong s leeve s hirts, l ong pant s, s ocks, s hoes, 
waterproof gl oves a nd pr otective ey ewear (USEPA 2 006).  I n addi tion, i n s ome 
situations, workers must use maximum protective controls, including closed mixing and 
loading systems and enclosed cockpits and trucks (USEPA 2006). Application of DCPA 
to ri ce fields t ypically oc curs t wice, onc e approximately 15 -25 days af ter t he r ice i s 
planted and again 10-15 days later.  At this time, the rice fields are flooded for 30 days 
and a third application is possible during the flooding period.  After the flooding period, 
crop f ields ar e dr ained and t he r ice i s s ubsequently har vested 140 -150 day s af ter 
planting.  The maximum rate of application of propanil, set by the USEPA, on rice fields 
is 8 lb/acre/season with an average use of 6 lb/acre/season (USEPA 2006). Application 
of DCPA on turf in commercial sod farms has a m aximum rate of 10 l b/acre (USEPA 
2006).   
Routes of exposure and risk assessment 
Workers i nvolved i n m anufacturing, hand ling or  appl ication of  propanil ar e at  
greatest risk but there have also been reports of non-occupational exposure, including a 
child under t he age of  6 (USEPA 2 006).  The r outes of  ex posure i nclude der mal, 
inhalation, i ngestion and c ontact wit h e yes. T he USEPA’s Registration El igibility 
Decision (RED) for propanil conducted a risk assessment which included determining a 
margin of  ex posure ( MOE) f or w orkers who ar e i nvolved i n m ixing, l oading an d 




considered a pot ential risk concern.  C ommercial propanil labels indicate that handlers 
should w ear l ong s leeve s hirts, l ong pa nts, s ocks a nd s hoes, waterproof gl oves an d 
protective ey ewear.  Using t his minimal and w idely u sed level of pr otection, the E PA 
determined that the MOE of all workers (in rice fields and turf) was less than 300, with 
several handling methods having a MOE less than 100.  In addition, in some situations, 
workers us ing m aximum pr otective c ontrols ( closed mixing an d l oading s ystems and  
enclosed cockpit, cabs or  t rucks) s till had a MOE of less than 300. Post occupational 
risk assessment, for workers entering treated areas 12 hours after application, was also 
conducted.  W orkers entering a f ield w ith maximum al lowable appl ication of  pr opanil 
had a MOE of less than 300 while turf workers involved in transplantation, fertilizing or 
mechanical w eeding or har vesting had a  M OE l ess t han 10 0.  Thi s a ssessment 
indicates that exposure to propanil is a risk concern for all workers, including those with 
maximal protection. 
Phytotoxicity  
In rice, as well as broadleaf plants and grasses, DCPA can translocate from the 
leaves t o t he gr owing s hoots an d then back t o ot her leaves. Th e t ranslocation and  
absorption of  D CPA oc curs at  s imilar r ates i n bot h r ice and pl ants t argeted by  t he 
herbicide (Carey V . F . 1995) .  T he phy totoxic ef fects of  D CPA a re i nfluenced by  t he 
ability of the plant to produce the enzyme acylamidase (Adachi 1966; Still and Kuzirian 
1967).  A cylamidase cleaves t he am ide b ond on DC PA and i nactivates i ts her bicidal 
activity (Yih, M cRae et al . 196 8) .  G aynor et al determined t hat, i n t he r ice p lants 
(Oryza sativa), ac ylamidase i s pr imarily localized t o t he out er m embrane of  t he 




than bar nyard gr asses and ar e able t o de grade DCPA t o avoid i ts phy totoxic ef fects.  
Inhibtion o f ac ylamidases c an occur dur ing c o-application w ith D CPA a nd c ertain 
organophosphorus or  c arbamate i nsecticides rendering t he r ice pl ants s usceptible to 
the phytotoxic effects of propanil (Matsunaka 1968; Chang, Smith et al. 1971).  Pla nts 
susceptible t o t he her bicidal ac tivity of  D CPA e xpress l ow l evels of  ac ylamidase an d 
phytotoxic effects occur primarily through the inhibition of photosynthesis.  Specifically, 
DCPA i nhibits t he p hotosynthetic el ectron c hain t ransport s ystem i n c hloroplasts 
(Matsunaka 1968) .  During ph otosynthesis t wo di stinct s tages ar e r equired f or t he 
synthesis of sugars.  In the light reaction chlorophyll absorbs a photon of light and loses 
an electron.  This electron gets passed through the electron chain transport resulting in 
the production of  NADPH (nicotinamide adenine dinucleotide phosphate).  I n addition, 
the l ight reaction also converts l ight energy into chemical energy stored in the form of 
ATP (adenosine triphosphate).  Both NAPDH and ATP are required for the conversion 
of CO 2 to s ugar t hat oc curs in t he dar k r eaction i n t he s troma of  c hloroplasts.  
Interruption of  the e lectron chain t ransport prevents the production of  sugars required 
for plant growth.  R ecently Yun et al reported that DCPA also inhibits the enzyme, 4-
coumarate:CoA l igase (Yun, Chen et al. 2007). 4-Coumarate is found only in the plant 
kingdom and upon binding t o t he cofactor, CoA ligase, plays an important r ole i n t he 
phenylpropanoid pathway, a pathway important in plant growth, mechanical support and 
cell wall rigidity.   
Metabolism  
In soil, plants and m ammals, metabolism of DCPA occurs by  hydrolysis o f t he am ide 




1968).  W hen McMillan et al treated rat hepatic microsomes with radio-labeled DCPA 
they i dentified D CA as  t he major m etabolite (McMillan, Fr eeman et  al . 199 0).  
Hydrolysis of the amide bond by hepatic acylamidases was supported when formation 
of DCA wa s inhibited wit h acylamidase i nhibitors.  I n addition, t hey i dentified 2 m inor 
metabolites pr oduced t hrough t he o xidation of  D CA; 6 -hydroxy-3,4-dichloroaniline 
(6OH-DCA) a nd N-hydroxy-3,4-dichloroaniline (NOH-DCA) (McMillan, Le akey et  al . 
1990).  Figure 1 out lines t he m etabolic pathway i n m ammals and t he s tructures o f 
DCPA and its major metabolites. 
The half life of DCPA in soil is reported to be 2-3 days (Chisaka and Kearney 1970; 
Konstantinou, Zar kadis et  al . 2001) . R ecovery of  pr opanil, i n s terile-treated s oil, i s 
almost 100% after incubation for 25 days (Chisaka and Kearney 1970).  Analysis of soil 
samples f rom r ice f ields t reated w ith D CPA r eveals t hat most of  t he D CPA i s 
metabolized w ithin 1 5 day s an d D CA an d pr opionic ac id c an be r eadily detectable.  
Microbial activity in the soil is thought to be responsible for the metabolic breakdown of 
propanil.  Acylamidase a ctivity i n bac teria i ncluding Pseudomonas striata and 
Pseudomonas fluorescens as well as t he f ungus Vibrio fisheri can c onvert D CPA t o 
DCA (Surovtseva and Funt ikova 1978;  Zabl otowicz, Loc ke et  al . 2001) .  Fusarium 
solani has also been reported to hydrolyze DCPA to produce DCA and pr opionic ac id 
(Lanzilotta and Pramer 1970).  T he propionic acid can serve as a c arbon source to F. 
solani to provide energy to the fungus.  However, it does not appear to be able to further 
degrade DCA and an increasing accumulation of DCA can result in inhibited growth of 
the fungus (Lanzilotta and Pramer 1970).  Microbial oxidation of propionic acid releases 





Figure 1: Metabolic pathway of DCPA in mammals 
 
Soils treated w ith propanil, at  near -field appl ication r ates (6lb/acre), reveal t hat 
70-80% of  t he D CA produced is c hemically boun d t o hum ic s ubstances ( Bartha and 
Pramer 1967; Bartha 1971). Degradation of the DCA-humic complex was estimated to 
take 5 -10yrs.  D CA c an al so c omplex w ith t he pl ant protein, l ignin, w ith n o appar ent 




unbound DCA can also form complexes with sugars to produce N-(3,4-dichlorophenyl) 
glucosylamine and other minor sugar conjugates (Still and Kuzirian 1967). 
There are also reports that two molecules of DCA, derived microbiologically from 
propanil, condense and form 3,3,’4,4’ tetrachloroazobenzene (TCAB) (Bartha 1971; Hill, 
Rollen et  al . 1981) . It has  been s uggested t hat m icrobiological ac tion, specifically 
peroxidase activity, is involved in the condensation of DCA to TCAB in soils (Bartha and 
Pramer 1967; Bordeleua 1972).  TCAB has not been found in plant tissues treated with 
DCPA (Still, B alba et  al . 1981) .  In a s tudy examining 99 s oil s amples from th e ri ce-
growing s tates of  A rkansas, C alifornia, Loui siana, M ississippi, an d Te xas, T CAB was 
detected i n 6 s amples (Carey, Yang et  al . 1980) .  P roduction o f TC AB i s thought t o 
occur pr imarily i n l oamy s oil and i s i nhibited under  dr y s oil c ondition ( Bartha 1971) .  
Workers involved in the manufacturing and packaging of DCPA report several adverse 
exposure effects including dizziness, nausea, muscle weakness, fatigue, and chloracne.  
Only the ef fect of  chloracne was directly related to the presence of  TCAB (Kimbrough 
1980). 
Ecological effects 
The ef fect of D CPA o n m icrobial c ommunities and aq uatic ani mals and pl ants 
has been well documented.  C ontamination of  waterways has  been reported to occur 
following release of water from flooded rice fields with reported DCPA levels of 0.1µg/l 
(0.1ppb) in soil water slurry and i rrigation water (Papadopoulou-Mourkidou, Karpouzas 
et al . 2004 ).  A s ingle appl ication of  D CPA ( 6 l b/ac), i n a c losed f looded r ice f ield, 
resulted i n a D CPA concentration of  200µ g/l ( 200ppb) af ter 24 hrs and de creased t o 




After 1 0-15 day s on ly m etabolites w ere det ectable. Th e hal f life of D CPA i n w ater i s 
reported to be approximately 2 days (Dahchour, Bitton et al. 1986). 
Several studies have documented the effects of DCPA on aquatic life.  Exposure of 
DCPA to fathead minnows (Pimephales promelas) has several deleterious effects with 
an LD 50 value of  3. 4mg/l ( 3.4ppm) af ter 192 hour s of  ex posure (Call, B rooke et  al . 
1983).  Ea rly lif e t oxicity w as obs erved at  3. 8µg/l (3.8ppb) and r esulted i n s ignificant 
decreases in egg hatch and i ncreases i n dead an d deformed hat ched m innows. B y 
post-hatch day 54 t he mortality rate was 100%.  S ignificant decreases in survival were 
also seen at 1.2µg/l (1.2ppb), w ith only 17% surviving pas t pos t-hatch day  54.  These 
levels are sufficiently high enough to affect fish populations in the rice paddy water or in 
the paddy water that is released near spawning or nursery grounds.  Adverse effects to 
DCPA have a lso been observed in f ish and f rogs.  The f rog species, Xenopus laevis, 
has a reported LD50 of 8.64mg/l (8.64ppm) 48 hours after exposure.  The 96 hr LC50 for 
the fish s pecies, Rainbow trout ( Oncorhynchus mykiss), Blue g ill (Lepomis 
macrochirus), and the fingerling channel catfish (Ictalurus punctatus) exposed to DCPA 
ranged from 2.3 - 6mg/l (2.3-6ppm) (McCorkle, Chambers et al. 1977) (Moore, Pierce et 
al. 1998)  (USEPA 2003).  Exposure of  t he metabolite DCA on z ebrafish, Danio rerio, 
results i n alterations i n early l ife stage dev elopment (Nagel, B resch e t al . 1991) .  
Deformations in the spine were observed a t 0.25mg/l DCA and an 11 day subchronic 
test ( 0.5mg/l) r evealed dec reases i n locomotor ac tivity and m ortality. Daphnia magna 
are al so v ery s ensitive t o D CA as  t he 48-hr LC 50 of 0. 14 m g/L ( 0.14ppm) (Pereira, 




Microbial communities within rice f ields are also altered dur ing exposure to DCPA.  
Exposure of 20µg/ml (20ppm) DCPA to the cyanobacterium, Anabaena MH, resulted in 
a significant inhibition of growth (Habte and Alexander 1980) with in a loss of more than 
85% of  i ts c holorphyll w ith no r ecovery af ter 10 day s of  ex posure.  A pplication of  




3,4-Dichloroaniline (DCA) i s t he m ajor metabolite of  D CPA as w ell as  other 
herbicides, including diuron and linuron.  In addition, DCA is used as an intermediate in 
the manufacturing of several pesticides, dyes and pharmaceuticals (ECB 2006).  DCA is 
persistent in soil and water but can be readily photodegraded in the atmosphere.  It has 
a ha lf l ife of  appr oximately 10 00 day s (ECB 2 006).  DCA i s s ubject t o c hemical 
oxidation, reacts with the organic matter insoil and has high volatility.  I n areas treated 
with propanil, large amounts of DCA are bound to soil particle making it unavailable for 
further metabolism or  pl ant upt ake (Bartha 1971) .  However, D CA r esidues c an be  
detected i n m ost c ommercial r ice (Oryza satiua) grain s amples at  a c oncentration of  
1µg/g of rice (Still 1968; SCTEE 2001).  Rats treated with an acute intraperitoneal (i.p.) 
injection of DCA reach maximum detection of DCA in the liver and plasma within 30-60 
minutes w ith l evels d ecreasing quickly within a f ew hours (Guilhermino, S oares et  al . 
1998).  Elimination of DCA in rats occurs after 3 days and is primarily excreted in urine 
and feces. I n humans, DCA has been  detected in the ur ine of  occupational and non-




2006) with levels in the 0.01-6.2µg/l range.  D CA-hemoglobin (Hb) adducts have  also 
been detected in workers involved in the application of  DCPA to rice f ields (Pastorelli 
1998).  Thes e addu cts w ere s till det ectable 4 m onths af ter t he last appl ication of  
propanil. 
N-hydroxy-3,4-dichloroaniline and 6-hydroxy-3,4-dichloroaniline 
N-hydroxy-3,4-dichloroaniline ( NOH-DCA) and 6 -hydroxy-3,4-dichloroaniline 
(6OH-DCA) ar e t he m ajor m ammalian metabolites of  D CA.  I n pr eparations of  r at 
hepatic m icrosomes, M cMillan et al detected 2 ox idative m etabolites, N OH-DCA a nd 
6OH-DCA (McMillan, Fr eeman et  al . 1990) . Fur ther s tudies i n c hromium-51 (Cr-51) 
labeled erythrocytes t reated w ith D CPA i ndicate t hat N OH-DCA c an u ndergo rapid 
redox cycling resulting i n t he oxidation of oxyHb to metHb.  Li ttle i s known about  t he 
effects of 6O H-DCA but i t i s al so i nvolved i n t he pr oduction of  m etHb, al though t he 
NOH-DCA metabolite is reported to be 10 times more potent (McMillan, Freeman et al. 
1990).  Methemoglobin (metHb) is a form of hemoglobin that does not bind or transport 





Using metHb levels as a marker for toxicity, the USEPA has assessed a t oxicity 
category for DCPA based on routes of exposure (USEPA 2003). Inhalation and dermal 
routes, the most common routes of exposure, were placed in Toxicity Category IV.  This 




exposure i s as signed a Tox icity C ategory I I, w ith c aution i ndicating s light t oxicity.  
Toxicity Category I I, w ith a ha zard w arning for m oderate t oxicity, w as i ndicated as 
studies demonstrated that DCPA is an eye irritant.  
Mutagenicity and carcinogencity 
Conflicting s tudies ar e av ailable t hat as sess t he pos sible m utagenic ef fects of  
exposure t o D CPA a nd i ts m etabolites.  Using t he S almonella t yphimurium r eversion 
assay, chemical-induced bas e c hanges or  frameshift mutations i n t he g enome of  t his 
organism can be m easured (McMillan, Shaddock et al . 198 8).  O ver a r ange of 
concentrations, pr opanil, D CA a nd N OH-DCA dem onstrated no increase i n m utations 
(McMillan, Shaddock et al. 1988).  The ability of propanil, DCA and NOH-DCA to induce 
mutations i n C hinese ham ster ov ary ( CHO) c ells w as al so assessed.  A lthough 
exposure of  al l 3 c hemicals decreased C HO c ell viability ov er a w ide r ange of  
concentrations, no changes in mutation rates were observed (McMillan, Shaddock et al. 
1988).  S imilarly, no  c hange i n D NA damage i n r at hepat ocytes w as observed.  
However, in more recent studies using the more sensitive Drospohila wing spot assay, 
larvae w ere t reated f or 3 day s w ith v arying c oncentrations of  D CPA. The w ing s pot 
assay can detect a loss of heterozygosity in suitable recessive markers that leads to the 
formation of mutant clones of cells that are then expressed as spots on t he wings.  I n 
these a ssays, D CPA does  i nduce genot oxic ef fects (Kaya, C reus et  al. 2000) .  A 
cytogenic assay on DCA indicated that exposure of DCA disturbs spindle formation but 




The USEPA has assessed DCPA for carcinogenic potential and has  determined 
that there is “suggestive evidence of carcinogenic potential by all routes of exposure but 




Early studies on the acute toxicological effects of DCPA established LD50 values for 
oral e xposure i n r ats and dogs  (Ambrose, Lar son et  al . 1972) . A n ac ute oral LD 50 of 
1384mg/kg for rats and 1217mg/kg for dogs was reported. Oral exposure to DCPA over 
a 7 day  period resulted in toxicity characterized by central nervous system depression 
within 12 hours of exposure.  In studies in Wistar rats, oral doses between 39-170mg/kg 
of DCA can alter body, spleen, liver and testis weight (Zhang and Lin 2009).  Inhalation 
studies s et an LD 50 concentration of  1.1mg/kg f or a 4hr  ex posure but  LD 50 
concentrations of  more than 5000mg/kg were reported for dermal exposure in rabbits 
(Stevens 1991).  Acute studies in male mice were conducted using a single i.p injection 
of DCPA at a dose of 400mg/kg (Singleton and Murphy 1973). Signs of toxicity included 
central nervous depression, loss of  r ighting reflex, and c yanosis. At higher doses, 600 
and 800 m g/kg, deaths occurred within 6 t o 24 hour s af ter injection. Rats treated with 
300mg/kg DCPA and triorthotolyl phosphate (TOTP), an enzyme that inhibits amidases, 
displayed no s igns of  c yanosis but  t he loss of  r ighting r eflex, C NS d epression or 
mortality remained (Singleton and Murphy 1973).  Thi s data suggests that cleavage of 





Due to the nature of  exposure there are l imited studies on t he effects of DCPA on 
humans.  However there are cases of occupational exposure and DCPA self-poisoning 
and that h elp c haracterize t he t oxicity of  D CPA.  D CPA s elf-poisoning h as bee n 
reported in Cuba and Japan, but in Sri Lanka, DCPA is the second most lethal herbicide 
used in deliberate self-poisoning cases (Eddleston, Rajapakshe et al. 2002) .  Between 
2002 and 2007 ov er 400 pat ients w ere i dentified in  s elf-poisoning c ases (Roberts, 
Heilmair e t al . 2009 ). S ymptoms o f DCPA po isoning i ncluded naus ea, v omiting, 
dizziness, i ncreased heart r ate, tissue hy poxia, c yanosis, m ethemoglobinemia a nd 
depression of CNS and respiratory system (Morse, Baker et al. 1979; Kimbrough 1980).  
Methemoglobinemia i s a w ell c haracterized ef fect of  D CPA e xposure i n hum ans an d 
animal models.  Methemoglobin (metHb) is a form of hemoglobin that does not bind or 
transport ox ygen.  M etHb l evels gr eater t han 20%  c an r esult i n decreased 
consciousness, c onvulsions, s hock and,  metHb abov e 70 % r esults i n de ath. 
Approximately 10% of  all patients in Sri Lanka died despite active t reatment (Roberts, 
Heilmair et al. 2009). The reported half life of DCPA, in the human body, was 3.2 hours 
but the concentration on D CA was detectable and more persistent than that of  DCPA 
(Roberts, Heilmair et al. 2009). 
The m echanism f or DCPA toxicity on er ythrocytes i s due t o t he f ormation of  the 
hydroxylated m etabolites, N OH-DCA and  6OH-DCA (Singleton and  M urphy 1973;  
Guilhermino, Soares et al. 1998).  In vitro studies in erythrocytes from Sprague-Dawley 
rat exposed t o D CA revealed n o i ncrease i n m etHb l evels (McMillan, Mc Rae e t a l. 




metHb with maximum metHb levels by 90 minutes.  S prague-Dawley rats injected with 
DCPA ( 100mg/kg) h ad det ectable l evels of  D CA an d N OH-DCA, i n t he bl ood, w hich 
reached peak concentration after 20mins and 4.5 hrs, respectively (McMillan, McRae et 
al. 1990) .  During m ethemoblobinemia, o xygen c arrying the ferrous i on ( Fe2+) o f th e 
heme gr oup of  t he hem oglobin m olecule i s oxidized by t he ox idative m etabolites of  
DCPA to t he f erric s tate ( Fe3+).  Thi s converts hem oglobin t o m ethemoglobin, a no n-
oxygen bi nding f orm of  hem oglobin t hat bi nds a w ater m olecule i nstead of ox ygen. 
Although b oth N OH-DCA a nd 6OH-DCA are k nown t o f orm metHb, th e N OH-DCA 
metabolite is reported to be 10 times more potent (McMillan, Freeman et al. 1990)  
In addi tion t o m ethemoglobinemia, hem olytic anem ia has  bee n obs erved as  a 
result of  ex posure t o pr opanil. In vivo and in vitro studies i n Sprague-Dawley r at 
erythrocytes demonstrated that N OH-DCA induced he molytic anem ia, but D CPA and 
DCA w ere not  di rect-acting hem olytic agent s (McMillan, B radshaw et  al . 1 991).  In 
addition, although 6OH-DCA can induce methemoglobinemia, it does induce hemolytic 
anemia (Chow and Murphy 1975).  
CHRONIC TOXICITY 
Chronic t oxicity s tudies w ere c onducted in r ats and  dogs  over a 2 y ear period 
and v arious par ameters w ere m easured ( Ambrose, Lar son et  al . 1972) .  In  ra ts, 
significant dec reases in body  weight ( from onset), mortality ( after 20 m onths) and Hb 
levels (after 3 m onths) were observed at  1600ppm.  I n add ition, higher organ-to-body 
weight r atios w ere al so r eported i n t he s pleen ( both s exes), l iver ( females on ly) and 
testes at  the 1600pp m dos e.  Studies i n dogs  r evealed no changes i n m ortality, 




studies i n r ats r evealed no adv erse ef fects i n w eight, r eproductive per formance, l itter 
size or  l itter m ortality and n o histopathological c hanges i n w eaned pups. D uring a 3 
month s tudy of  s ubchronic or al ex posures i n r ats, s urvival w as onl y af fected at  t he 
highest c oncentration ( 50,000ppm) (Ambrose, Lar son et  al . 197 2).  D ecreases i n H b 
levels were observed at all doses above 1000ppm indicating hemolytic anemia.  Several 
increases i n organ-to-body weight r atios were al so observed.  A t a dos e of  3300ppm 
increases i n k idney a nd l iver r atios i n on ly t he f emales w ere obs erved.  I ncreases i n 
spleen r atio w ere ob served i n only t he f emales at  t he 1000p pm dos e.  A t t he hi gher 
dose (10000ppm) increased testes ratio in the males and increased heart ratios in both 
the males and females were noted.  A similar 4-week study was conducted in dogs with 
decreased food consumption and weight observed only the two highest doses (10000 
and 50000ppm) (Ambrose, Larson et al. 1972). 
Reproductive Toxicity  
In studies with Wistar rats, oral doses between 39-170 mg/kg of DCA decreased 
testis weight.  In addition, alterations in several testicular enzymes suggests modulatory 
effets of  s permatogenesis, t esticular dege neration, and pos sible det erioration of  t he 
germinal epithelium (Zhang, Pan et al. 2009).  DCA has also been shown to weakly bind 
the andr ogen r eceptor and is su spected as ac ting as  an endoc rine di sruptor (Bauer, 
Meyer et al. 1998; USEPA 2006). 
Nephrotoxicity 
There ar e v arious r eports on the to xicity o f NOH-DCA and D CA in t he k idney. 
Exposure to DCPA, DCA and NOH-DCA has been reported to result in renal cytotoxicity 




ex vivo experiments, r enal c ortical s lices were exposed to varying c oncentrations of  
DCPA an d i ts m etabolite and c ytotoxicity w as det ermined by  m easuring lactate 
dehydrogenase ( LDH) levels.  E xposure to 500µM NOH-DCA r esulted in significant 
cytotoxicity but higher concentrations were required for s imilar results i n renal cortical 
slices exposed to DCPA (1mM), DCA ( 2mM) and pr opionic acid (5mM).  D ecreases in 
glutathione l evels were obs erved and cytotoxicity w as r eversed by  addi tion of  
glutathione i n N OH-DCA exposed s amples, i ndicating an i ncrease i n t he oxidation of  
glutathione in order to neutralize the intermediate NOH-DCA.  
IMMUNOTOXICITY 
The i mmune s ystem i s a c omplex s ystem c omprised of  i nnate and ad aptive 
responses t hat r equire s urveillance and b alance t o ensure an  opt imal r esponse t o 
foreign at tacks.  I n humans, t he dev elopment of  i mmune c ells beg ins i n t he bon e 
marrow.  P luripotent s tem c ells c an d ifferentiate down 2 p athways: myeloid or 
lymphoid.  Differentiation down the myeloid pathway results in the production of colony 
forming uni ts-spleen (CFU-S) progenitor cells that give r ise to erythrocytes, platelets, 
granulocytes and m onocytes. In a C 57/B6 mouse model of acute exposure to DCPA, 
there was a dose dependent decrease in CFU-S cells as well erythroid burst forming 
units (BFU-E), progenitor cells f or erythrocytes (Blyler, Landreth et al . 1994)  Similar 
results ar e al so r eported i n hum an bl ood c ord pr ogenitor c ells but exposure t o D CA 
appears less toxic (Malerba, Castoldi et al. 2002).  
Early toxicological studies revealed al terations in both the spleen and the thymus.  
The spleen-to-body weight ratio was increased in albino rats exposed to oral doses of 




year per iod (Ambrose, Lar son et al . 197 2).  I n C 57/B6 m ice an i .p. i njection of  
200mg/kg of  pr opanil, or  a m olar-equivalent dos e of  D CA ( 150mg/kg) r esulted i n 
increased spleen weight and s ize ( Barnett and G andy 1989;  B arnett, Gandy et  al . 
1992).   Decreases in thymic weight were also observed in DCPA treated mice but not 
DCA treated mice (Barnett, Gandy et al. 1992; Zhao, Schafer et al. 1995). In addition to 
thymic at rophy, s everal t hymocyte subpopulations were al so d ecreased.  S ignificant 
concentration dependent decreases in thymic CD3+CD4+CD8+ and CD3+CD4+CD8- 
populations were seen at all doses (100-200mg/kg) but no changes were observed in 
the spleen or mesenteric lymph nodes (Zhao, Schafer et al. 1995). 
 
INNATE AND ADAPTIVE IMMUNITY 
Innate and adapt ive i mmune r esponses a re t he t wo m ain c omponents of  an  
active immune response.  I nnate immunity is a m echanism of protection that does not 
require s pecific r ecognition of ant igens a nd i s i mportant i n t he ear ly d etection of  
pathogens. A daptive i mmunity i s an an tigen-specific r esponse t hat i ncludes bot h 
humoral and cell-mediated immunity.  Alterations in both innate and adaptive responses 
have been reported after exposure to propanil (reviewed in (Salazar, Ustyugova et  al. 
2008)). 
Innate Immunity 
Adverse e ffects of  exposure of D CPA t o m acrophages have be en w ell 
documented.  In vivo studies with peritoneal macrophages from C57/B6 mice exposed 
to 200mg/kg DCPA resulted in the decreased production and secretion of IL-6 and TNF-




IL-6 and TNF-α production in LPS-stimulated macrophages (Xie, Schafer et  al . 1997) .  
Ex vivo experiments w ith per itoneal macrophages resulted i n s imilar dec reases (Xie, 
Schafer et al. 1997).  I n addition, the ability of LPS-stimulated peritoneal macrophages 
to phagoc ytose w as also dec reased wit h c oncomitant dec rease in r eactive o xygen 
species ( ROS), r eactive ni trogen s pecies (RNS) and  i nducible nitric ox ide synthase 
(iNOS) (Ustyugova, Frost et al. 2007).  In the human monocytic cell line, THP-1, TNF-α 
secretion and phagoc ytosis w as al so i nhibited (Ustyugova, Fr ost et  al . 2007) .  The 
mechanisms for these decreases may be due to a decrease in the p65 subunit of NF-κB 
and t o alterations in i ntracellular c alcium (Ca) homeostasis (Xie, S chafer et  al . 1997;  
Frost, Neeley et al. 2001).  I n addition to macrophages, natural killer (NK) cells appear 
to be s ensitive t o t he ef fects of  D CPA an d D CA.  Exposure of  DCPA an d i ts m ajor 
metabolite, DCA, results in decreased NK lytic ac tivity.  C 57/B6 mice t reated with 75-
200mg/kg D CPA ( or t he m olar equ ivalent of  DCA) r esulted i n d ose-dependent 
decreases in the ability of NK cells to lyse target cells (Barnett, Gandy et al. 1992).   
 
Adaptive Immunity 
B cell response 
Recognition of foreign antigens and the production of antigen-specific antibodies 
are important functions for B cells. Immature B cells are produced in the bone marrow 
and develop from a progenitor B cell to a Pro-B cell to a pre-B cell and finally reach an 
immature B c ell s tage, where i t ex presses I gM, and m igrates t o t he s pleen f or 
differentiation into a  mature B cell.  Several s tudies indicate that the humoral immune 




have i ncreased s pleen s ize an d w eight but t he m echanism f or t his obs ervation i s 
unknown. Decreased pr e-B and  I gM popul ations i n t he bone m arrow of  C57/B6 mice 
exposed DCPA were observed 7 days post exposure but return to normal 24 days post-
exposure (de la Rosa, Barnett et al. 2003).  Exposure of C57/B6 mice to 400mg/kg of 
DCPA also reduced t he pr oliferation of  LP S-stimulated B  c ells ( Barnett and G andy 
1989).  Initial t oxicological s tudies i nvestigating t he e ffects of  D CPA on t he i mmune 
response r evealed t hat i .p. ex posure of  DCPA or  D CA, i n C 57/B6 m ice, l eads t o 
decreased in T cell-dependent and T cell-independent antibody responses (Barnett and 
Gandy 1989; Barnett, Gandy et  a l. 1992) .  Interestingly, C57/B6 mice immunized with 
heat-killed Streptococcus pneumoniae and exposed to DCPA have a dos e-dependent 
increase in the number of phosphocholine (PC)-specific IgM, IgG2b and IgG3 antibody 
secreting B cells (ASC) in the spleen (Salazar, de la Rosa et al. 2005).  At 7 days post-
exposure, the number of ASC had increased 4-6 fold with no increases in the number of 
ASC in the bone marrow or serum. The reason for this increase has not been elucidated 
but t he m echanism appears t obe ovary-dependent, estrogen and  pr ogesterone-
independent but requires a f unctioning steroid synthesis pathway (Salazar, Miller et al. 
2006).  Male mice produce a smaller increase in PC-specific ASC compared to females 
when e xposed t o DCPA but  t his increase i s t estes-independent (Salazar, M iller e t a l. 
2006). 
T cell response 
T c ells p lay an i mportant r ole i n c ell-mediated i mmunity and i nvolve s pecific 
recognition of foreign antigens leading to the production of antigen-specific antibodies 
through C D4+ T c ells or t he t argeted destruction of  i nfected cells ( CD8+ T  c ells).  




to CD4+ helper T cells and CD8+ cytotoxic T c ells. As mentioned above, exposure to 
DCPA results in a  significant decrease in the CD3+CD4+CD8+ and CD3+CD4+CD8- 
thymic subpopulations (Zhao, Schafer et al. 1995).  Mixed lymphocyte reactions (MLR) 
and delayed-type hypersensitivity (DTH) reactions were both reduced in C57/B6 mice 
exposed to high doses of  DCPA (400mg/kg) (Barnett and Gandy 1989) .  I n add ition, 
concavalin-A (con-A)-stimulated splenocytes, from mice treated with DCPA, resulted in 
decreased pr oliferation as  w ell as  dec reased I L-2 and I L-6 pr oduction (Barnett and 
Gandy 198 9; Zhao,  S chafer et  al . 1998) . Fur ther s tudies, us ing m urine ( EL-4) and  
human ( Jurkat) T c ell lines, demonstrated a dose depe ndent-decrease i n I L-2 
production, at  low concentrations of  DCPA (25-100µM) when stimulated with PMA or 
PMA/ionomycin (Io), respectively (Zhao, Schafer et al. 1999; Brundage, Schafer et al. 
2004).  I n the EL-4 cell line, transcription and stability of the IL-2 mRNA was inhibited 
and in Jurkat cells, decreases in the amount and phosphorylation of c-jun, one of  two 
proteins t hat m ake u p t he t ranscription f actor A P-1, r esulted in the decreased D NA 
binding ability of AP-1. 
Cytotoxic CD8+ T cells are responsible for identifying infected cells and secreting 
lytic proteins, such as perforin, granzymes and granulysin, in order to kill infected cells.  
Investigations of  t hymic s ubpopulations d emonstrated t hat C D3+CD4-CD8+ T  c ells 
were decreased (Zhao, Schafer et al. 1995). However, studies investigating the effects 
of DCPA and DCA, demonstrated that neither the parent compound nor its metabolite 
impaired c ytotoxic T c ell activity (Barnett, G andy et al . 1992).  More re cently, i t has  




function, secondary stimulation of mice CD8+ T c ells, in the absence of further DCPA 




T CELL ACTIVATION AND SIGNALING 
T c ell r ecognition of  a f oreign peptide pr esented o n a m ajor histocompatibility 
complex ( MHC )  on the s urface of  an a ntigen pr esenting c ells (APC), a long w ith co-
stimulation of  C D28, sets i nto m otion a  c omplex series of  signaling events t hat 
culminates in the activation of a T cell (reviewed in (Smith-Garvin, Koretzky et al. 2009).  
The TCR is comprised of a series γε, δε, and ξξ dimers that associate with a single αβ 
heteromer.  Thes e d imers c ontain s pecific i mmunoreceptor t yrosine-based ac tivation 
motifs (ITAMs) consisting of 2 tyrosines that flank an amino acid sequence that contains 
key leucine and i soleucines.  Li gation of the TCR results in the recruitment of cytosolic 
Src f amily pr otein t yrosine k inases ( Lyn and Lc k) t hat ph osphorylate t yrosines 
associated w ith I TAMs and t hereby pr ovide a doc king s ite f or Zap -70.  Zap -70 i s a 
70kDa phosphoprotein belonging to the Syk kinase family. Recruitment of Zap-70 leads 
to a c ascade of  phos phorylation ev ents i mportant i n t he ac tivation of  dow nstream 
pathways.  Two key targets of Zap-70 are the adapter proteins, linker of the activation of 
T cells (LAT) and S rc homology-2 (SH2) domain-containing leukocyte phosphoprotein 
(SLP-76).  These 2 pr oteins help to s tabilize the TCR complex and organize ef fectors 
proteins t o al low f or ac tivation of m ultiple pat hways.  LA T pr oteins c an bi nd t he S H2 
domain of PLC-γ and as well as adapter proteins GRB2 (growth factor receptor bound 
protein-2) and Gads (GRB2-related adapter downstream of Shc).  SLP-76 interacts with 
the S H2 d omains an d ac tivates adapt er pr oteins V av1, N ck and I tk ( IL-2-induced 
tyrosine k inase).  A ll t hese pr oteins h elp t o i ncrease t he s tability of  t he c omplex an d 




mediated pathways, cytoskeletal rearrangements and i ntegrin activation (Smith-Garvin, 
Koretzky et al. 2009). 
Early s ignaling ev ents, depend ent on L AT and SLP-76 ac tivation, r esult i n t he 
recruitment of  P LC-γ1 to t he TCR complex.  O nce ac tivated, P LC-γ1 hydrolyzes t he 
membrane l ipid p hosphatidylinositol 4, 5-bisphosphate ( PIP2) r esulting i n t he 
production of  di acylglycerol ( DAG) and  i nositol 1,4,5-trisphosphate (IP3).   D AG 
remains in the membrane where it plays a r ole in the activation of the Ras and PKCθ 
pathways.  Ras-GRP ( Ras g uanyl nuc leotide-releasing pr otein) c ontains a D AG-
binding domain t hat r ecruits i t t o t he membrane where it is phosphoylated by PKCθ 
and can then convert RAS-GDP to the ac tive Ras-GTP. Ras-GTP ac tivates Raf-1, a  
Ser/Thr k inase, and p hosphorylates and ac tivates MAPK (mitogen-associated protein 
kinase) pa thway. A ctivation of  t he M APK pat hway l eads t o ac tivation of  E lk, a 
transcription factor important for the expression of c-fos. Dimerizatrion of c-fos and c -
jun form AP-1, an important transcription factor required for early gene expression.  In 
addition to activation of the MAPK pathway, DAG also recruits PKCθ to the membrane 
through its DAG-specific lipid-binding domain and activates the NF-κB pathway (Quest, 
Ghosh et al . 1997).  Activation of NF-κB  occurs when its inhibitory molecule, IκB, is 
phosphorylation by the IκB kinase (IKK) complex (Wan a nd Len ardo 2010) .  
Phosphorylation of IκB marks it for ubiquitination and degradation and allows NF-κB to 
translocate into the nucleus where it acts as a transcription factor for genes involved in 









PLC-γ hydrolysis of PIP2 a lso results i n t he pr oduction of  I P3. IP3 i s r eleased 
into the cytosol where is binds to its receptor, IP3-R on the ER membrane resulting in 
the r elease of  C a f rom t he E R s tores.  U pon depletion of  t he E R s tores, S tim1, a 
transmembrane pr otein on t he ER, aggr egates and  i nitiates c lustering o f O rai1, a  
plasma membrane protein, leading to the activation of CRAC channels and the influx of 
Ca into t he c ell ( described in detail in  Chapter 5)  (Barr, B ernot et  al . 2008).  Th is 
increase in cytosolic Ca, through the CRAC channels, triggers several signaling events 
that ar e critical f or T  c ell f unction.  NFAT i s a  tra nscription factor th at i s s trictly 
regulated by C a and c ooperatively b inds t o D NA t o control t he ex pression of  genes  
important i n T c ell ac tivation an d f unction (Jain, Loh et  al . 1995;  R ooney, S un et  al . 
1995).  In resting T cells, NFAT is phosphorylated at several Ser residues and resides 
in the cytosol but upon stimulation, is dephosphorylated by calcineurin and can freely 
translocate i nto t he nuc leus.  The i nflux of  C a t hrough C RAC c hannels f ollowing 
activation of T cells is essential for the activation of NFAT.  Binding of Ca, to the 4 ion-
binding sites on calmodulin (CaM), leads to the activation of calcineurin (Cn).  Cn is a 
calmodulin-dependent s erine/threonine ph osphatase w ith 2 s ubunits; a c atalytic 
subunit (calcineurin A) and a regulatory subunit (calcineurin B) (Feske 2007).  The Ca-
CaM c omplex bi nds t o t he r egulatory s ubunit of  C n t hereby ac tivating i ts c atalytic 
activity. O nce ac tivated, C n de -phosphorylates N FAT and  ex poses a nuc lear 
localization s equence ( NLS) w hich l eads t o bi nding of importins and t ranslocation o f 
NFAT into the nucleus.  In the nucleus, NFAT acts in a c oordinate manner with other 
transcription f actors t o ac tivate s pecific ge nes r equired f or T c ell ac tivation, f unction 




dependent on s ustained Ca influx and c alcineurin ac tivity. A  dec rease in intracellular 
Ca l evels or t reatment w ith t he c alcineurin i nhibitor c yclosporin A  r esults i n t he 
immediate ex port of  N FAT f rom nuc leus b y N FAT k inases and  al terations i n gen e 
expression (Gwack, Feske et al. 2007). 
 
T CELLS AND ION CHANNELS 
CRAC channels 
In T c ells, i nflux of  Ca i s r egulated through Ca r elease-activated C a ( CRAC) 
channels.  Activation of the IP3 receptors on t he surface of  the ER releases Ca f rom 
internal ER stores resulting in the aggregation of the ER transmembrane protein, Stim1.  
Stim1 is a single transmembrane protein that exists as a monomer when ER Ca stores 
are full (Manji, Parker et al. 2000).  During T cell activation, ER stores are depleted and 
Ca i s r eleased f rom t he E F-hand dom ain, l ocated in t he lumen of  t he ER.  S tim1 
dimerization oc curs and aggr egates, or  pun cta, form in ar eas w ithin 10 -25µm of  t he 
plasma membrane initiating clustering of Orai1 proteins on t he plasma membrane and 
activation of t he C RAC c hannel (Liou, K im et  al. 2005;  W u, B uchanan et al . 2006 ).  
Orai1 is a 4 transmembrane spanning protein with both the N- and C-terminus located 
in the cytoplasm (Yeromin, Zhang et al. 2006).  Clustering of 4 Orai1 subunits forms the 
pore forming unit of CRAC channels (Xu, Lu et al. 2006).  The complete CRAC channel 
complex h as not  bee n el ucidated but  expression of  Stim1 and Orai1 ar e sufficient to  
produce a C RAC current (ICRAC) (Li, Lu et  a l. 2007;  Salido, Sage et  al . 2009) .  CRAC 
channels w ere or iginally des cribed us ing electrophysiological methods but  t he r ecent 




 CRAC channels are characterized by  ac tivation through ER s tore depletion, an 
extreme selectivity for Ca and a low conductance rate, or the rate of ion travel through 
the c hannel (Parekh 2006) . T  c ells a re s mall in  s ize, 5 -10 µm , and,  at  rest, t he 
intracellular C a c oncentration i s ar ound 50 nM ( estimated t o be about  10, 000 f ree C a 
ions) s o a v ery s mall, C a s elective c urrent, on the s cale of  pi coamps, i s c apable of  
evoking a substantial r ise i n t he c oncentration of  c ytosolic Ca  (Cahalan a nd C handy 
2009). The selectivity of Ca through CRAC channels is such that monovalent ions are 
excluded by i on-pore and  i on-ion i nteractions (McNally, Y amashita et  al . 2 009).  
Absence of extracellular divalent ions allows the flow of monovalent ions but addition of 
very l ow c oncentrations of  C a blocks b locks m onovalent p ermeation t hrough h igh 
affinity C a bi nding t o t he c hannels.  The pr esence of  one C a i on i s s uggested t o be  
sufficient to block monovalent flow through the channel (Prakriya 2009).    
CRAC regulation 
CRAC channels can be regulated by  several mechanisms (DeHaven, Smyth et  
al. 200 7; Hogan and  R ao 200 7).  Ca -dependent p otentiation ( CDP) enhances C RAC 
activity through increases in extracellular Ca.  The r eversal of this, depotentiation, can 
decrease CRAC activity when extracellular Ca is removed. The mechanism for this is 
unknown but the degree of potentiation is dependent on the pore occupancy by divalent 
ions, w hereby i ons with hi gher per meability s upport gr eater potentiation.  C RAC 
channels are al so r egulated t hrough f ast i nactivation w here I CRAC decreases in 
hyperpolarizing env ironments. L astly, i t has  been pr oposed t hat hi gh i ntracellular C a 
surrounding CRAC c hannels i nhibits C RAC ac tivity and t hereby pr oduce an i nhibitory 




been reported that CRAC channels may be regulated by the refilling of  the ER stores 
and the reversal of Stim1 puncta formation. It is hypothesized that as ER Ca stores are 
refilled, Stim1 dimers disassemble and monomeric Stim1 can bind Ca through i ts EF-
hand domain leading to a di sruption of  the Stim1/Orai1 assembly (Smyth, Dehaven et 
al. 2008; Fahrner, Muik et al. 2009).   
CRAC inhibitors 
CRAC channels can be differentially regulated by 2-APB (2-aminoethyldiphenyl borate).  
At l ow c oncentrations ( 1-5µM) 2 -APB c an i ncrease I CRAC 2-5 f old but  at  hi gher 
concentrations (>10µM) i t s trongly inhibits I CRAC (Peppiatt, Collins et  al . 2003; Peinelt, 
Lis et al. 2008).  At inhibitory concentrations of 2-APB, reversal of Stim1 puncta can be 
observed in HEK293 cells over-expressing Stim1 (DeHaven, Smyth et al. 2008; Peinelt, 
Lis et al. 2008). However, when Orai1 is overexpressed no effect is observed indicating 
that di sruption of  S tim1-Orai1 i s not  t he m echanism of  ac tion (Navarro-Borelly, 
Somasundaram et  al. 2008) . E nhancement of  CRAC ac tivity at  l ow 2 -APB 
concentrations has  b een pr oposed t o be  m ediated t hrough r ecruitment of  C RAC 
channels t hat f acilitates t he as sociation between S tim1 and O rai1(Navarro-Borelly, 
Somasundaram et al. 2008; Wang, Deng et al. 2009).  Recently analogs of 2-APB have 
been reported t o i nterrupt S tim1 punc ta f ormation but  t he specificity of  t hese analogs 
are unknown (Goto, Suzuki et al.).  I n T cells, inhibition of  CRAC channels decreases 
Ca influx and inhibits T c ell function, which in humans, leads to a SCID-like syndrome 
characterized by an inability to activate T cells (Feske, Gwack et al. 2006; Thompson, 




OTHER ION CHANNELS AND PUMPS 
SERCA 
T c ells a lso e xpress ot her i on c hannels t hat m odulate c ytosolic C a.  
Sarco/Endoplasmic reticulum Ca-ATPase (SERCA) pumps are located on the ER and 
function to pump Ca out of the cell.  Thapsigargin (Tg) is a commonly used inhibitor that 
irreversibly inhibits the SERCA pump and its used to actvivate CRAC channels. 
PMCA 
Plasma m embrane Ca-ATPase (PMCA) pum ps a re l ocated on t he p lasma 
membrane of T cells.  At rest, PMCA are autoinhibited and when cytosolic Ca increases 
pump activity is initially slow.  O ver tens of seconds the Ca-Cam complex binds the C 
terminus of PMCA and displaces the inhibitory domain. The PMCA pump plays a role in 
modulating Ca signaling and al so to prevent the accumulation of Ca in the cytosol that 
can lead to apoptosis. 
RyR 
Ryanodine receptors (RyR) are located on the ER and are activated by changes 
in Ca , as w ell as  t hrough bi nding of  cADP r ibose a nd NAA DP.  RyR f acilitate t he 
movement of Ca from ER stores to the cytosol and a re important in later Ca signaling 
events. 
Na/Ca exchanger 
Sodium/calcium (Na/Ca) exchangers are located on t he plasma membrane and 




it in the mitochondria or exporting i t out  of  the cell.  M ovement of  Ca in o ne di rection 
occurs with the concomitant movement of Na in the other direction. 
Ca uniporter 
Ca uni porters ar e l ocated on t he m itochondira and are ac tivated by  hi gh C a 
levels in the cytosol.  They are involved in sequestering Ca inside the mitochondria to 
prevent accumulation of Ca inside the cell. 
Potassium (K+) channels 
T ce lls express 3  types of  K+ channels; Kv, KCa, and TR PM.  Kv and TR PM4 
and TRPM5 are activated by the depolarization of the plasma membrane (an increase 
of pos itive c harge inside t he c ell). K v c hannels f unction t o i ncrease t he C a driving 
potential by exporting K+ ions.  TRPM channels have been r eported to inhibit the Ca 
driving force but their function in T cells is controversial. 
Non-store-operated cation channels 
There have been s everal reports of other cation channels that are not activated 
by ER C a depl etion.  TRPV6(CaT1) channels are constitutively ac tive, n on-selective 
cation c hannels on t he pl asma m embrane t hat ar e i nhibited b y i ncreases i n c ytosolic 
Ca.  TRPM2(LTPC7) channels are also plasma membrane bound and are activated by 
pyrimidine nuc leotides, A DPR ( adenosine 5 ’- diphosphoribose) and N AD ( nicotiamide 
adenine d inucleotide) and pr oduce a no nselective cation c hannel.  T RPM7(MIC) 
channels a re al so no nselective cation c hannels t hat are ac tivated by  i ntracellular M g 
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Stimulation of  T c ells t hrough t he T c ell r eceptor ( TCR) r esults i n t he ac tivation of  a 
series of  s ignaling pat hways t hat l eads t o t he s ecretion of  I L-2 and c ell pr oliferation.  
Influx of calcium (Ca2+) from the extracellular environment, following internal Ca2+ store 
depletion, provides t he e levated and  s ustained intracellular c alcium c oncentration 
([Ca2+]i)  c ritical fo r o ptimal T  c ell a ctivation.  O ur l aboratory has  doc umented t hat 
exposure t o t he he rbicide 3, 4-dichloropropionanilide ( DCPA) i nhibits i ntracellular 
signaling events that have one or  more Ca2+ dependent s teps.  Herein we report that 
DCPA at tenuates the normal elevated and  sustained [Ca2+]i that follows internal s tore 
depletion in the human leukemic T c ell line, Jurkat cells, and pr imary BALB/c mouse T 
cells.  DCPA did not alter the depletion of internal Ca2+ stores when stimulated by anti-
CD3 or t hapsigargin demonstrating t hat e arly IP 3-mediated signaling and depletion o f 
Ca2+ stores were unaffected. 2-aminoethyldiphenol borate (2-APB) is known to alter the 
store-operated Ca2+ (SOC) in flux that follows Ca2+ store depletion. Exposure of Jurkat 
cells t o ei ther D CPA or  50 µM 2 -APB at tenuated t he i ncrease i n [ Ca2+]i following 
thapsigargin or  ant i-CD3 induced s tore depletion i n a s imilar m anner.  A t l ow 
concentrations, 2-APB enhances SOC influx but this enhancement is abrogated in the 
presence of D CPA. This a lteration i n [ Ca2+]i, wh en exposed t o D CPA, significantly 
reduces nuclear NFAT levels and IL-2 secretion without altering the plasma membrane 
polarization pr ofile.  Tak en t ogether, t hese dat a i ndicate t hat D CPA i nhibits T c ell 






The herbicide DCPA, commonly referred to as propanil, is widely used and a pplied 
several times throughout the growing season.  I t is applied predominantly on rice fields 
for control against several broadleaf and grassy weeds but, was recently registered for 
use on t urf.  A nnual use of  D CPA i s es timated t o be 7 m illion pounds  p er y ear an d 
represents use on 50-70% of all rice crops in the United States.  The broad application 
and heav y us e of  t his her bicide under scores t he i mportance of  i nvestigating i ts 
immunotoxic effects.  
The effects of DCPA on mammalian immune cells have been well documented (Xie, 
Schafer et al. 1997; Zhao, Schafer et al. 1998; Brundage, Schafer et al. 2004; Salazar, 
Miller et  a l. 2006;  Sheil, Fr ankenberry et  al . 20 06; C orsini, Codeca et  al . 20 07; 
Ustyugova, Fr ost et  al. 2007) .   In vivo administration of  D CPA t o m ice r esults in 
decreased ex vivo cytokine production by macrophages (IL-1β, IL-6 and TN F-α) and T 
cells (IL-2 and I FN-γ)(Barnett 1992; Zhao, Schafer et al. 1998). Previous studies using 
LPS-stimulated m acrophages demonstrated a dec rease i n [ Ca2+]i after ex posure t o 
DCPA(Xie, Schafer et al. 1997).  Using the murine EL-4 T cell line and human Jurkat T 
cell lines, we have demonstrated that exposure to DCPA decreased IL-2 production and 
IL-2 m RNA le vels (Zhao, S chafer et  al . 1999;  B rundage, S chafer et  al . 2004) .  In  
addition, Jurkat T cells exposed to DCPA demonstrate decreased DNA binding ability of 
the t ranscription f actor, ac tivating pr otein-1 ( AP-1), and dec reased c -jun pr otein 
(Brundage, Schafer et  al . 2004) .  The pr oduction of  I L-2, an i mportant ear ly cytokine, 
requires t he c oordinate ac tivation of  t ranscription f actors, A P-1, NF -ĸB, and NFAT, 




Activation of  T c ells i s i nitiated through recognition of  a pept ide presented on t he 
surface of  an ant igen pr esenting c ell, al ong w ith c o-stimulatory i nteractions, w hich 
triggers a s eries of  ev ents i ncluding p hosphorylation of  t he TC R c omplex an d 
recruitment of  k inases and a dapter pr oteins t o t he pl asma m embrane ( PM).  
Subsequent ac tivation of  phos pholipase-Cγ1 (PLC- γ1) r esults i n t he hy drolysis of  
phosphatidylinositol 4 , 5 bi sphosphate ( PIP2) and  t he pr oduction of  t wo s econd 
messengers, di acylglycerol ( DAG) and i nositol 1,  4 , 5 t riphosphate ( IP3) (Feske, 
Okamura et al. 2003; Panyi, Varga et al. 2004).  DAG remains in the PM and activates 
proteins such as protein kinase C (PKC).  IP3 is released from the PM and interacts with 
the I P3-receptor (IP 3-R) on t he surface of  the endopl asmic r eticulum ( ER) r esulting i n 
the release of Ca2+ from the ER.  Depletion of ER Ca 2+ stores activates SOC channels 
located on  t he P M al lowing f or t he i nflux of  C a2+ from t he ex tracellular e nvironment.  
This r esults i n an increased a nd s ustained [ Ca2+]i and ac tivation, v ia c almodulin, o f 
calcineurin which leads to the dephosphorylation of NFAT and its translocation into the 
nucleus.  Once in the nucleus NFAT acts as a transcription factor for the production of 
key cytokines (Feske, Okamura et al. 2003).  Ca 2+ also plays a role in the activation of 
the t ranscription f actors N F-κB, and AP-1(Lewis 2 001; Q uintana, G riesemer et  al . 
2005). C ooperative bi nding of  t hese t hree t ranscription f actors i s r equired f or opt imal 
transcription and pr oduction of  I L-2, an e ssential early c ytokine r equired f or T c ell 
proliferation and differentiation (Garrity, Chen et al. 1994).  
 The importance of  calcium as a s econd messenger in T cell activation has been well 
established (Lewis 2001; Quintana, Griesemer et  al . 2005; Feske 2007)  Two coupled 




The f irst mechanism i nvolves an i nitial i ncrease i n [ Ca2+]i through t he I P3-mediated 
depletion of ER Ca2+ stores.  Thi s transient increase is necessary but not sufficient for 
optimal T cell activation (Feske, Gwack et al. 2006).  Emptying of the ER Ca2+ stores is 
coupled to the ac tivation of  Ca2+-release ac tivated Ca2+ (CRAC) channels on the PM.  
Upon E R store depl etion STIM-1 ( stromal i nteraction m olecule-1) r edistributes i nto 
puncta on  t he E R and ac cumulates c lose t o t he P M ( Zhang, Y u et  al . 2005;  W u, 
Buchanan et al. 2006; Xu, Lu et al. 2006). Orai1 (also known as CRACM1) has recently 
been described as an essential pore subunit of the CRAC channel (Prakriya, Feske et 
al. 2006; Vig, Peinelt et al. 2006). During T cell activation, aggregation of STIM-1 on the 
ER i nduces c lustering of  O rai1 on t he P M r esulting i n an i nflux of  C a2+ through t he 
CRAC channel (Xu, Lu et al. 2006).  This increase in [Ca2+]i through the CRAC channels 
is essential for the activation of transcription factors necessary for cytokines production.  
Defects i n the C RAC c hannel h ave bee n r eported i n patients w ith s evere c ombined 
immunodeficiency ( SCID) s yndrome, under scoring t he i mportance of  C a2+ in T c ell 
activation (Feske, Draeger et al. 2000; Feske, Giltnane et al. 2001; Feske, Prakriya et 
al. 2005).   
Due t o t he i mportance of  C a2+ homeostasis i n T c ell ac tivation and f unction, w e 
investigated the effect of DCPA on [Ca2+]i  in T cells, using primary BALB/c mice T cells 
and the Jurkat human T cell leukemia cell line. The human Jurkat T cell line, has been 
used as  a m odel for human T c ell s ignaling for over 2 decades (Abraham and W eiss 
2004). When investigating the immunotoxic effects of DCPA, Jurkat cells are a valuable 
tool t hat al lows elucidation of  mechanisms involved i n exposure t o DCPA.  S ince our  




more clearly the immunosuppressive role of DCPA on T cells. Our experiments indicate 
that D CPA i nhibits T  c ell ac tivation by  attenuating i ncreases i n [ Ca2+]i following t he 




MATERIALS AND METHODS 
Cell lines 
Experiments were performed using the human T cell leukemia cell line, Jurkat clone E6-
1, obt ained f rom the A TCC ( American Tissue C ulture C ollection, M anassas, V A).  
Jurkat c ells w ere m aintained i n c omplete R PMI ( Mediatech I nc., H erndon, V A) 
supplemented w ith 10% heat  i nactivated f etal bov ine serum (v/v) (FBS) (Hyclone I nc. 
Logan, U T), 100 u nits/ml pe nicillin ( BioWhittaker), 100 µg/ml s treptomycin (B io 
Whittaker), 20 m M glutamine (BioWhittaker) and 5 0 µM 2-mercaptoethanol (Sigma, St. 
Louis, MO).  The cultures were kept at 37°C in 5% CO2. 
Mice 
Female B ALB/c m ice ( 8-10 w eeks ol d) were pur chased f rom C harles R iver La bs 
(Wilmington DE).  M ice were housed in the vivarium at West Virginia University Health 
Sciences Center under the care of a f ull time veterinarian and professional staff.  They 
were given access to food and w ater ad libitum and allowed to acclimate to the facility 
for at  l east 1 -week prior t o us e. Experiments w ere c onducted in ac cordance w ith al l 
federal an d i nstitutional g uidelines f or an imal us e a nd w ere approved b y t he W est 
Virginia University Institutional Animal Care and Use Committee. 
Isolation of Mouse T cells 
Spleens f rom BALB/c m ice were r emoved aseptically, pooled a nd m ade i nto a s ingle 
cell s uspension.  R ed bl ood c ells w ere l ysed us ing Tris-NH4Cl and r esuspended in 
sorting buffer (PBS, 0.5% bovine serum albumin and 2 mM EDTA) at 2.5 x 105 cells/ml.  
An enr iched ( >90% by  f low c ytometry) popul ation of T c ells w as i solated t hrough 




Briefly, spleen cells were incubated at 4°C for 10 min with a cocktail of biotin-conjugated 
monoclonal ant ibodies s pecific for C D14, C D16, C D19, C D36, C D56, C D123, and  
Glycophorin A , as  des cribed i n t he m anufacturer’s protocol ( Miltenyi B iotec).  N ext, 
monoclonal ant i-biotin ant ibody-conjugated m agnetic m icrobeads w ere added t o t he 
sample an d i ncubated f or 15 m in at  4 °C.  Cells were washed with sorting buf fer an d 
resuspended at  1 ×  10 8 cells i n 500 µl o f c old buf fer.  C ells were t hen l oaded ont o 
autoMACS c olumns ( Miltenyi B iotec) and  pur ified T  c ells w ere c ollected t hrough a 
negative s election process.  P urified T c ells w ere s timulated us ing ant i-CD3 ( BD 
Bioscience) and g oat ant i-Armenian ham ster ant ibody ( Jackson I mmunoResearch, 
West G rove P A) t o c rosslink t he ant i-CD3 as pr eviously des cribed ( Kubo, B orn et  al . 
1989).   
Fluorescence Measurement of [Ca2]i  
Jurkat cells or splenic mouse T c ells were loaded with the calcium-indicator dye f luo-3 
AM ( Invitrogen, C arlsbad, C A) as pr eviously des cribed ( Grynkiewicz, P oenie et  al . 
1985). Br iefly, c ells we re h arvested and r esuspended t o a c oncentration of  5 × 106 
cells/ml an d i ncubated f or 30 m in ( 37°C in  5 % CO 2) i n c omplete R PMI m edia ( 1.5% 
FBS, v /v) containing 0. 1 µM  f luo-3 A M  i n t he pr esence of  0. 02% pl uronic F -127 
(Invitrogen) and 2. 5 mM probenecid (Sigma, St. Louis, MO).  C ells were then washed 
twice i n C a2+ and M g2+-free H anks B alanced S alt Solution ( HBSS) ( Mediatech, I nc, 
Herndon, VA) c ontaining 10 m M H EPES, pH  7. 4, 2 % FB S a nd 2. 5 m M pr obenecid, 
resuspended t o a c oncentration of  1 × 106 cells/ml and i ncubated 30 m in at  r oom 
temperature.  S ince t he addi tion of  2%  FB S i s es sential f or c ell v iability t he m edia 




temperature and protected from light until ready for analysis.  2 × 106 cells were placed 
in a q uartz c uvette and t he f luorescence w as m easured us ing a P TI Q M-2000-4 
spectrofluorometer ( Photon Te chnology I nternational ( PTI), B irmingham, N J) w ith 
constant s tirring.  The  f luorescence of  the f luo-3 dye was measured with excitation at 
490 nm  a nd em ission at  525 nm.  S tock s olutions of  D CPA ( ChemServices, W est 
Chester, PA) and 2-APB (CalBioChem, San Diego, CA) were diluted in absolute ethanol 
(AAPER A lcohol and  C hemical C ompany, S helbyville, K Y).  V ehicle s amples w ere 
treated w ith an  equ ivalent c oncentration ( 0.1%v/v) of  et hanol.  The f luorescence was 
measured and digitized at 1 Hz using the software program FeliX 1.42b (PTI).  In Jurkat 
cell, approximately 45 s after starting data collection, 2.0 µl of DCPA, 2-APB or vehicle 
was added to the cuvette, followed immediately by mouse anti-human CD3 antibody at 
a f inal concentration of  5.0 µg/ml (UCHT1) (BD Biosciences, San Diego, CA). Splenic 
mouse T c ells were stimulated with anti-CD3 (BD Bioscience) and goat anti-Armenian 
hamster ant ibody (Jackson I mmunoResearch, W est G rove P A) t o c rosslink t he ant i-
CD3 as previously described (Kubo, Born et al. 1989).  When the fluorescence returned 
to bac kground levels, Ca Cl2 (Fluka, S witzerland) w as added ( final c oncentration 2. 5 
mM) to the media to provide an  ex ternal source of  Ca2+.  A ddition of  ionomycin ( final 
concentration 200  µM ) ( Sigma, S t. Loui s, MO) pr ovided ev idence t hat t he cells were 
loaded evenly and that the dye remained in the cytosol.  C ell membranes were lysed 
with 0.1%, v/v Triton X-100 (Fisher Scientific, Hampton, NH) to measure the maximum 
fluorescence (Fmax) parameter for calculation of [Ca2+]i, to monitor compartmentalization 
of t he dy e and ens ure t he am ount of  dy e w as not  a l imiting f actor.  E thylene gl ycol-




added to a final concentration of 50 m M (pH 7.5) to lower the free Ca2+ to a nominally 
Ca2+-free level (Fmin).   
Fluorescence values were converted to [Ca2+]i using the following equation:  
free[Ca2+]i = KD[(F-Fmin)/(Fmax-F)], 
where K D (360 nM ) i s t he di ssociation c onstant of  t he Fl uo-3/Ca2+ complex, F i s t he 
measured f luorescence intensity, F min is t he m inimum f luorescence at  very low [Ca2+]i 
(fluorescence after the addition of 50 mM EGTA) and Fmax is the fluorescence measured 
at high [Ca2+]i (fluorescence after the addition of Triton X-100) (Grynkiewicz, Poenie et 
al. 1985).  The bac kground fluorescence obtained from unloaded cells over a 3 m inute 
time period was subtracted from all data points before [Ca2+]i was calculated. 
Measurement of IL-2 Production 
 Jurkat cells were cultured in complete RPMI media or RPMI media without Ca2+ at 5 × 
105 cells/well i n 48 -well p lates ( Costar, C orning, N Y) c oated w ith m ouse ant i-human 
CD3 antibody (10 µg/ml)(BD Sciences).  Cells were treated with 25, 50, 100, or 200 µM 
DCPA, or vehicle control.  DCPA solutions were diluted in absolute ethanol and vehicle 
control samples were given an equivalent amount of absolute ethanol (0.1% v/v).  Cells 
were al so s imultaneously s timulated w ith ant i-CD28 ant ibody ( 2 µg/ ml) ( BD 
PharMingen, San Diego, CA).  Cells were incubated at 37°C in 5% CO2 for 48 h af ter 
which s upernatants w ere c ollected and placed at  -20°C.  I L-2 pr oduction w as 
determined us ing t he s andwich E LISA method a nd f ollowing t he m anufacturer’s 
protocol (BD PharMingen).  All cultures and ELISA analyses were performed in triplicate 





Jurkat cells were cultured to 1 x  106 cells/ml in complete RPMI and s timulated with 10 
ng/ml P MA (S igma-Aldrich) and 1 µg/ ml A 23187 ( Sigma-Aldrich).  C ells w ere t reated 
with 0.1% v/v ethanol (vehicle control), 100 µM DCPA or received no treatment.  After a 
1, 2, 4, and 6 h exposure, cells were harvested and centrifuged at 1200 rpm for 8 min at 
4°C.  Nuclear extracts were prepared as previously described (Schreiber, Matthias et al. 
1989).  Briefly, cells were resuspended in 1ml PBS, pelleted, resuspended in cold buffer 
A ( 10mM H epes p H 7. 9, 10m M K CL, 0 .1 m M E DTA ( disodium ethylenediamine 
tetraacetate), 0 .1 mM E GTA, 1 mM D TT (d ithiothreitol) and 0 .5 mM P MSF 
(phenylmethanesulfonyl fluoride)) and incubated on ice for 15 min.  After incubation, 25 
µl of a 10% solution of Nonidet NP-40 was added, vortexed and centrifuged for 30 s at 
14,000 rpm.  Supernatants, containing the cytoplasmic fraction of the cells, were frozen 
at –70°C. The nuc lear pellet was resuspended in cold buffer C (20 mM Hepes pH 7.9, 
0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and 1 mM PMSF) and incubated on 
ice for 15 min with vortexing every 5 min.  Samples were centrifuged for 5 min at 14,000 
rpm and t he supernatants containing t he nuclear f raction were s tored at  –70°C.  T he 
protein concentrations of  t he nuc lear ex tracts were determined us ing Coomassie plus 
protein assay reagent kit following the manufacturer’s protocol (Pierce, Rockford, IL). 
Western Blots 
A 30  µg aliquot of  each nuc lear extract was boi led for 5 m in to denature the proteins 
and electrophoresed through an 8% Tr is polyacrylamide gel  with a 4% stacking gel at  
25 mAmps for 18 h. Proteins were  t ransferred onto Hybond-P membranes (Amersham 




at room temperature, blocked for 1 h in TBS + 0.1% Tween 20 (TBS/T) plus 5% dry milk 
at r oom temperature and t hen w ashed t hree t imes i n TB S/T.  Blots w ere i ncubated 
overnight a t 4°C w ith primary ant ibodies specific f or t otal NFATc2 ( Santa C ruz Santa 
Cruz, CA) or β actin (Santa Cruz) in TBS/T plus 5% BSA.  The next day, blots were 
washed t hree t imes i n TB S/T, i ncubated f or 1 h at  r oom t emperature w ith ant i-Biotin 
(Cell S ignaling Tec hnology, I nc., D anvers, M A) and ei ther a goat  ant i-mouse I gG-
horseradish per oxidase (HRP) (Santa C ruz) o r a  ra bbit a nti-goat I gG-HRP ( Sigma-
Aldrich).  Fi nally, t he bl ots w ere w ashed three t imes i n TB S/T and dev eloped us ing 
Phototope-HRP detection k it f or w estern b lots ( Cell Signaling Technology, I nc) and 
bands w ere v isualized on X -Ray f ilm ( BioMax M R, E astman K odak C ompany).  
Densitometric anal ysis w as per formed us ing O ptimus s oftware ( Media C ybernetics, 
Silver S pring, M D) a nd nuc lear N FAT pr otein l evels w ere nor malized t o ac tin pr otein 
levels for each sample. 
Measurement of membrane potential  
The membrane potential of  Jurkat cells was measured us ing the membrane potential-
sensitive DiB AC4(3) dy e ( Invitrogen). T his bi s-oxonol dy e produces an ex citation 
maximum at approximately 490nm. As the cell depolarizes increasing amounts of  dye 
enters t he c ell w here i t bi nds t o i ntracellular pr oteins or  m embranes and ex hibit 
enhanced f luorescence. C onversely, hy perpolarization i s i ndicated by  a dec rease i n 
fluorescence. DiBAC4(3) is excluded from mitochondria because of i ts overall negative 
charge, al lowing m easurement of t he pl asma m embrane pot ential (Wolff, Fuks e t a l. 
2003).  Membrane potential experiments were carried out in a time course similar to the 




Mg2+-free Hanks B alanced S alt S olution ( HBSS) ( Mediatech, I nc,) c ontaining 1 0 m M 
HEPES, pH 7.4 and 2% FBS containing 20nM DiBAC4(3).  Samples were kept at room 
temperature and protected f rom l ight unt il ready for analysis.  A  1.0 ml (1 × 106 cells) 
aliquot of loaded cells was placed in a FACS tube and the fluorescence was measured 
using a  FACSCalibur f low cytometer ( Becton D ickson, Fr anklin L akes, N J). E ach 
recorded t ime point consisted of  10,000 cells.  A t t=0 a bac kground f luorescence was 
recorded after which DCPA, or vehicle control was added, followed immediately by anti-
CD3 ant ibody at  a f inal c oncentration of  5 .0 µg/ ml ( BD B iosciences).  Fl uorescence 
measurements w ere r ecorded i mmediately f ollowing t reatment a nd ant i-CD3 addi tion 
(t=1 min) and again at t=3 min and t=5 min.  External Ca2+, in the form of CaCl2, (Fluka, 
Switzerland) w as s ubsequently added ( final c oncentration 2. 5 m M) to t he c ells t o 
provide an  ex ternal source of  Ca2+.  Fl uorescence measurements were collected at  3  
time points following addition of external Ca2+ (t= 5.5, 6.5, and 9.5 min).  Addition of 40 
µl K Cl ( final concentration 100  mM) completely depo larized t he cell a nd f luorescence 
values were recorded at  t=10, 12 and 14 m in.  B ackground f luorescence of  unloaded 
cells w as s ubtracted f rom al l dat a poi nts bef ore t he net  c hange i n f luorescence was 
calculated.  The f luorescence was represented as  the net  change in the f luorescence 
signal as a percent of  the initial background f luorescence (Fo) of  the T c ells at  rest as 
described by ΔF/Fo= ( Ft-Fo)*100/Fo (where F t is t he f luorescence at  eac h time poi nt) 
(Wolff, Fuks et al. 2003) . 
Statistical Analysis 
All data were analyzed using MS Excel 2003 (Redmond, WA) and Sigma Stat 3.1 (Port 




increase of [Ca2+]i over a s elected time period.  The  AUC includes all data points from 
the t ime t he e xternal C a2+ was adde d un til t he [ Ca2+]i reached a p lateau and  w as 
calculated us ing S igma S tat 3.1.  The peak  [Ca2+]i was calculated by  determining the 
highest [ Ca2+]i between addi tion of  C aCl2 and addi tion of  i onomycin.  S everal c urves 
were us ed f or eac h s ample an d t he m ean ±  S .D. i s r eported.  A  t -test w as used to 
determine s tatistical s ignificance f or al l C a2+ fluorescence an d m embrane pot ential 
experiments.  ANOVA was used to determine statistical significance in IL-2 production.  





Effect of DCPA on [Ca2+]i in Anti-CD3 Stimulated Jurkat Cells 
T cell activation and proliferation requires a cascade of signaling events mediated by 
two Ca2+ sensitive mechanisms.  The f irst involves the IP3-mediated depletion of  Ca2+ 
stores i n t he E R an d i s c oupled t o t he s econd m echanism, t he ac tivation of  C RAC 
channels and the influx of Ca2+.  To determine the effect of DCPA on [Ca2+]i Jurkat cells, 
loaded w ith f luo-3 in a nom inally Ca2+-free (2.5 µM) HBSS solution, were t reated w ith 
25, 50,  100,  200 µM  DCPA or  vehicle (ethanol) control and s timulated w ith ant i-CD3. 
We det ermined t hat DCPA and  et hanol, h ereafter r eferred t o as  t he v ehicle, di d not 
interfere w ith t he f luorescence of  t he f luo-3 dy e ( data not  s hown).  Ther e w as n o 
significant difference between cells stimulated with anti-CD3 or cells that were exposed 
to v ehicle and s timulated w ith anti-CD3 ( data not  s hown).  A s s hown in Fi gure 1, 
addition of DCPA or vehicle followed by stimulation with anti-CD3, in a nominally Ca2+-
free env ironment, r esulted i n an  equi valent s mall, t ransient i ncrease i n f luorescence.  
This increase in the [Ca2+]i represents the depletion of IP3-sensitive Ca2+ stores and its 
subsequent r emoval out  of  t he c ell by  activated C a2+-ATPases or  i ts s equestration 
within the cell (Fig. 1A).  D CPA and v ehicle t reated cells exhibited s imilar changes in 
[Ca2+]i indicating that DCPA does not affect the early IP3-mediated signaling pathway or 
the depletion of internal Ca2+ stores.  
In T cells, optimal activation of several transcription factors requires a sustained and 
elevated [ Ca2+]i that i s m aintained by  C a2+ influx t hrough C RAC c hannels f ollowing 
internal C a2+ store depl etion.  To det ermine i f D CPA a lters [ Ca2+]i following s tore 
depletion  we added Ca2+ to the media following anti-CD3 induced store depletion (Fig. 




and addition of external Ca2+, where the fluorescence intensity, seen in Figure 1A, was 
converted t o an [ Ca2+]i.  A  de crease i n t he [ Ca2+]i, following store depl etion was 
observed in Jurkat cells exposed to al l four DCPA concentrations, when compared to 
the v ehicle c ontrol ( Fig. 1A  and B ).  C ells w ere f urther t reated with Tr iton X -100 t o 
monitor compartmentalization and ensure that t he amount of  available dye was not  a 
limiting f actor.  I n addition, Tr iton X -100 a nd EGTA provided m aximum an d m inimum 
fluorescence values, respectively, to calculate the [Ca2+]i. (See Material and Methods).  
Similar fluorescent levels after addition of ionomycin, Triton X-100 and EGTA were seen 
independent of treatment (Fig. 1A).  
 To further quantify the at tenuation of  the [Ca2+]i  following store depletion the area 
under the curve (AUC), peak [Ca2+]i, and time to peak, were calculated.  The AUC was 
calculated for each sample to determine the relative amount of free Ca2+ in the cytosol 
over a 103 s   time per iod ( t= 3 37-440 s ).  The A UC and pea k [ Ca2+]i data f or c ells 
exposed to increasing concentrations of DCPA and stimulated with anti-CD3 are shown 
in F igure 1C a nd D.  E xposure of  c ells to 200 µM DC PA r esulted in a  s ignificant 
decrease (79%) in the AUC and the peak [Ca2+]i (78%).  A 56% decrease in the AUC 
and a 52%  dec rease i n t he pea k [ Ca2+]i was obs erved i n c ells t reated w ith 100 µM.  
Cells t reated w ith 25  and 50 µ M D CPA a lso r esulted i n dec reases i n A UC and peak 
[Ca2+]i. Although t he d ecreases o bserved i n t he pr esence of  25 and 50 µM w ere no t 
statistically s ignificant they highlight the t rend in the concentration dependent ef fect of  
DCPA.    In addition, the time to reach peak [Ca2+]i, following addition of external Ca2+, 
increased with i ncreasing c oncentration of  D CPA e xposure.  V ehicle c ontrol c ells 




and 200 µ M D CPA r esulted i n a peak  [Ca2+]i at appr oximately 75, 81,  93 and 108 s , 
respectively.  Tak en t ogether, t hese r esults dem onstrate t hat ex posure t o D CPA 
decreases [ Ca2+]i following a nti-CD3 i nduced s tore depl etion i n a c oncentration 







Figure 1 . DCPA de creases i ntracellular cal cium in a con centration depende nt 
manner. 
Jurkat c ells w ere l oaded w ith f luo-3 and at  50s , ant i-CD3 w as added s imultaneously 
with 25, 50, 100, 200 µM DCPA or vehicle control and changes in (Ca2+)i were recorded 
with a spectrofluorometer.  At 335 s, the external [Ca2+] concentration was increased to 
2.5 m M wit h Ca Cl2.  S tarting at 442 s , ionomycin, Tr iton X -100 an d EGTA w ere 
sequentially added t o t he c ell m edia at  t he t imes i ndicated.  A, a r epresentative 
experiment of the complete fluorescence curve in the absence (solid line) and presence 








Figure 1B : DCPA d ecreases i ntracellular cal cium i n a conc entration dependent  
manner.   
Fluorescence intensity data from Figure 1A were used to calculate [Ca2+]i  for the time 









Figure 1C  and 1D . DCPA d ecreases intracellular cal cium i n a concent ration 
dependent m anner.   C, Statistical an alysis of  t he area under  t he c urve ( AUC) f or 
DCPA and  vehicle control f rom 3 separate experiments.  D, s tatistical ana lysis of  t he 
peak [ Ca2+]i for D CPA and v ehicle c ontrol f rom 3 s eparate ex periments.  Error bar s 
reflect t he ±  S .D. a nd as terisks ( *) i ndicates s tatistically s ignificant r esults, p< 0.05.  





The Effect of DCPA on Thapsigargin Stimulated Jurkat Cells 
To det ermine i f e xposure t o DCPA af fected t he ear ly I P3-induced s ignaling pat hway, 
the S ERCA pum p i nhibitor t hapsigargin was us ed.  Thaps igargin dep letes E R Ca2+ 
stores and pr events r efilling, t hereby ac tivating C a2+ influx t hrough C RAC c hannels 
independent of  IP3 production (Bergling, Dolmetsch et  al . 1998).  The addi tion of  100 
µM DCPA or vehicle control f ollowed by 2  µM thapsigargin resulted i n an  equivalent 
small, t ransient i ncrease i n f luorescence, s imilar t o t hat obs erved w ith ant i-CD3 
stimulation (Fig 2A).  However, t he normal i ncrease in [Ca2+]i, f ollowing in ternal Ca 2+ 
store depl etion, i s s ignificantly decreased i n D CPA-treated c ells, c ompared t o t he 
vehicle control cells. (Fig. 2A and B).  Cells t reated with thapsigargin and ex posed to 
100 µM DCPA exhibited a s ignificant decrease in the AUC and peak [Ca2+]i similar to 
that observed with anti-CD3 stimulation (Figure 2C and D).  D uring a 70s  t ime period 
(t=360-430s) D CPA e xposed c ells e xhibited an appr oximately 50% dec rease i n t he 
AUC and an approximate 55% decrease in the peak [Ca2+]i.  Thi s data indicates that 
early IP3-induced signaling events and depletion of ER Ca2+ stores were not affected by 
the ex posure of  J urkat c ells t o D CPA. H owever, t he addi tion of  ex tracellular C a2+ 
following store depletion resulted in an overall decrease in the available free cytosolic 








Figure 2A. DCPA does not affect early IP3-mediated signaling or depletion of ER 
Ca2+ stores. 
Jurkat c ells w ere l oaded w ith f luo-3 i n a nom inally C a2+-free s olution.  A t 50 s , 
thapsigargin w as ad ded s imultaneously with 1 00µM D CPA or v ehicle c ontrol a nd 
changes in ( Ca2+)i were r ecorded w ith a  spectrofluorometer.  At 375 s , t he e xternal 
[Ca2+] was raised to 2.5 mM with CaCl2.  Starting at 430 s, ionomycin, Triton X-100 and 
EGTA w ere s equentially add ed t o t he c ell m edia at t he t imes i ndicated.  A, a 
representative ex periment of  the c omplete f luorescence c urve of  v ehicle c ontrol 








Figure 2B. DCPA does not affect early IP3-mediated signaling or depletion of ER 
Ca2+ stores. Fluorescence intensity data from Figure 2A were used to calculate [Ca2+]i  
for the time frame of interest (t=360-430 s).  These time points represent the influx of Ca 







Figure 2C and 2D. DCPA does not affect early IP3-mediated signaling or depletion 
of ER Ca2+ stores. C, statistical analysis of the AUC for DCPA and vehicle control from 
3 s eparate e xperiments.  D, s tatistical a nalysis of t he peak  [ Ca2+]i for DCP A a nd 
vehicle control from 3 separate experiments.  Error bars reflect the ± S.D. and asterisks 
(*) indicates statistically significant results, p<0.05.  S tatistical analysis was performed 





The Effect of DCPA and 2-APB on [Ca2+]i   
To f urther c haracterize t he ef fect of  D CPA on  [ Ca2+]i, w e c ompared D CPA-induced 
inhibition to that seen with 2-APB, a known inhibitor and enhancer of Ca2+ influx through 
CRAC c hannels(Prakriya and L ewis 20 01).  At l ow c oncentrations ( <5 µM ) 2 -APB 
enhances Ca2+ influx through CRAC channels but at higher concentrations (>10 µM) it 
inhibits Ca2+ influx (Prakriya and  Lewis 2001).  Sin ce 2-APB has been shown to a lter 
Ca2+ influx following store depletion we compared the effects of 2-APB on [Ca2+]i to that 
of DCPA. 
Jurkat cells were stimulated with anti-CD3 and the change in [Ca2+]i was measured  
in cells t reated with vehicle control, 100 µM  DCPA, 2.5 µM 2-APB, 50 µM 2-APB or a 
mixture of  100 µM  D CPA a nd 2.5 µM  2 -APB ( Fig. 3A ).  A s e xpected t here w as n o 
change in the release of Ca2+ from internal stores regardless of treatment, except for the 
cells exposed to 50  µM 2 -APB ( data not  shown). H igh concentrations of  2 -APB have 
been reported to affect IP3-mediated signaling in addition to inhibiting Ca2+ influx but IP3 
signaling is not  af fected at  l ower enhanc ing c oncentrations of  2 -APB (Prakriya and  
Lewis 20 01). Fi gure 3A s hows the c hanges i n [ Ca2+]i following s tore de pletion an d 
subsequent addition of external Ca2+. Cells treated with 2.5 µM 2-APB demonstrated a 
significant i ncrease i n [ Ca2+]i compared t o t he v ehicle c ontrol w hereas 50 µM 2 -APB 
abrogates the increase in the [Ca2+]i (Fig. 3A).  When cells were simultaneously treated 
with 100 µM DCPA and 2.5 µM 2-APB the enhanced effect of 2-APB was abrogated.  
Cells treated with DCPA or 50 µM 2-APB revealed significant decreases in the AUC 
and the peak [Ca2+]i, as compared to the vehicle control (Fig. 3B and C). The AUC and 
peak [Ca2+]i were significantly increased (30%) in cells treated with 2.5 µM 2-APB (Fig. 




exhibited a 30%  de crease i n the A UC and peak  [Ca2+]i  when c ompared t o t he 
enhanced influx of 2.5µM 2-APB (Fig. 3B and C).  Together these results provide further 
evidence t hat, f ollowing s tore-operated Ca2+ depletion, DCPA-exposed cells dec rease 
[Ca2+]i in a  s imilar manner as 2-APB and DCPA interferes with the ab ility o f 2-APB to 












Figure 3A. The effect of DCPA and 2-APB on [Ca2+]i  
Jurkat cells were loaded with f luo-3 in a no minally f ree Ca2+solution.  A nti-CD3 
was added simultaneously with 100 µM DCPA, 2.5 µM 2-APB, 50 µM 2-APB, a 
mixture of 100 µM DCPA and 2.5 µM or vehicle control (solid line).  Fluorescence 
changes in ( Ca2+)i was r ecorded w ith a  s pectrofluorometer and c onverted t o a 
[Ca2+]i.  A, a r epresentative e xperiment of  t he c onversion of  t he f luorescence 







Figure 3B and 3C. The effect of DCPA and 2-APB on [Ca2+]i. B, statistical analysis of 
the AUC for DCPA, 2-APB (2.5 µM and 50 µM), 100 µM DCPA plus 2.5 µM 2-APB and 
vehicle control f rom 3 separate experiments.  C, statistical analysis of  the peak [Ca2+]i 
for DCPA, 2-APB (2.5 µM and 50 µM), 100 µM DCPA plus 2.5 µM 2-APB and vehicle 
control from 3 s eparate ex periments.  E rror bar s r eflect t he ±  S .D. and asterisks ( *) 
indicates statistically significant change compared to vehicle control, p<0.05.  Statistical 




The Effect of DCPA on Membrane Potential 
It is well known that changes in the membrane potential of T cells can alter Ca2+ influx 
(Sarkadi, Tor dai et  al . 1990) .  To det ermine i f t he ef fect on [ Ca2+]i seen in  DCP A-
exposed c ells w as d ue t o a lterations in t he m embrane p otential J urkat cells w ere 
loaded with the membrane potential sensitive dye, DiBAC4(3).  As the cell depolarizes 
increasing am ounts of  t he D iBAC4(3) dy e ent ers t he cell m embrane r esulting i n an  
increased fluorescence signal whereas a decrease in the fluorescence signal indicates 
hyperpolarization.  J urkat cells were exposed to 100µM DCPA or vehicle control and  
stimulated with anti-CD3 in a nominally Ca2+-free buffer.  Changes in the fluorescence 
signal us ing f low cytometry are depicted i n Figure 4.   The  background resting T  cell 
fluorescence w as r ecorded at  t =0. Fl uorescence m easurements w ere t aken 
immediately f ollowing t he s imultaneous a ddition of  t he t reatment and ant i-CD3 ( t=1 
min), t hen agai n at  t =3 m in and t =5 min. Ex ternal Ca 2+ was t hen added an d 
fluorescence m easurements w ere t aken immediately at t =5.5 m , t =6.5 and  t =9.5 m .  
Addition of 50 mM KCl at t=10 min depolarized the cell and demonstrated that the dye 
responds to this depolarization.  Further f luorescence measurements were also taken 
at t =12 an d 14 m in. This dat a dem onstrates t hat t he D CPA-induced at tenuation o f 











Figure 4 DCPA doe s not  al ter t he m embrane p otential of ant i-CD3 st imulated 
Jurkat cells. Jurkat cells were loaded with DiBAC4(3) in a nominally Ca2+ free solution 
and ana lyzed v ia f low c ytometry. O pen c ircles ar e D CPA-treated c ells a nd c losed 
triangles are v ehicle c ontrol c ells.  A t t =0 t he ba ckground r esting p otential w as 
recorded. Fl uorescence m easurements w ere t aken i mmediately f ollowing addition o f 
anti-CD3 a nd t reatment ( t=1 min), t hen agai n at  t =3 m in and t =5 m in. E xternal C a2+ 
(2.5mM C aCl2) w as then adde d and f luorescence measurements w ere recorded a t 
t=5.5 m in, t=6.5 and t =9.5 m in.  50 m M K Cl w as ad ded t o dep olarize t he c ells a nd 
fluorescence measurements were taken at t=10, 12 a nd 14 min. Error bars reflect the 






Effect of DCPA on IL-2 Secretion in Jurkat cells  
A r eduction i n t he el evated [ Ca2+]i following s tore de pletion has  di rect dow nstream 
affects on Ca2+-dependent pathways.  In order to establish a functional consequence of 
exposure to DCPA we assessed its effect on IL-2 secretion.  I L-2 is an essential early 
cytokine r equired f or T c ell proliferation and d ifferentiation. The ac tivation of  
transcription factors NF-κB, NFAT and AP-1, depend, to varying degrees, on the [Ca2+]i 
and are important in production of IL-2. Jurkat cells were stimulated with anti-CD3 and 
anti-CD28 and exposed to 25, 50, 100, or 200 µM DCPA or vehicle control.  After 48 h 
in c ulture, IL -2 l evels i n t he s upernatant w ere as sayed v ia a s andwich E LISA.  The  
results of  a r epresentative experiment are shown in Table 1.   I n the presence of  2.5 
mM extracellular Ca2+, DCPA decreased IL-2 production in a concentration-dependent 
manner, with no detectable IL-2 production when exposed to 200 µM DCPA.  Exposure 
of J urkat c ells t o 100  µM  D CPA i nhibited I L-2 pr oduction by  72%.  I n ex periments 
performed with t he s ame D CPA and v ehicle c ontrol c oncentrations but  w ith nom inal 





















Treatment IL-2 % control 
No treatment 3420±272 97.4 
Vehicle control 3510±564 100.0 
25 µM DCPA 2720±169 77.5 
50 µM DCPA 2262±312 64.4 
100 µM DCPA 968±245 27.6 
125 µM DCPA 1171±137 33.4 
200 µM DCPA <32a  
Note:IL-2 is measured in µg/ml ± SD 




Effect of DCPA on Nuclear Translocation of NFAT 
In order t o es tablish a di rect m echanistic consequence of  D CPA on  t he i nhibition of 
Ca2+-dependent signaling events we examined the Ca2+-dependent transcription factor 
NFAT.  A sustained [Ca2+]i via Ca2+ influx results in the calmodulin-stimulated activation 
of t he pr otein phos phatase, c alcineurin ( Lewis 20 01; Fes ke, O kamura et  al . 2003;  
Quintana, G riesemer et  al . 20 05). C alcineurin dep hosphorylates c ytoplasmic N FAT 
allowing i ts t ranslocation i nto t he nuc leus w here i s ac ts as  a t ranscription f actor f or 
many genes, including IL-2. To assess the effect of DCPA on NFAT we measured the 
levels of nuclear NFAT at various time points after T cell stimulation.  Jurkat cells were 
treated w ith v ehicle c ontrol, 100µM  D CPA or no t reatment and s timulated w ith P MA 
and A23187.  After 1, 2, 4 or 6 h incubations nuclear extracts were made and the level 
of nuclear NFAT was determined by western blot.    Cells exposed to 100 µM  DCPA 
exhibited decreases in nuclear NFAT at all time points (Fig. 5A and 5B).  Densitometric 
analysis of  the decrease in nuc lear NFAT in DCPA-treated Jurkat cells indicated that 
100 µM DCPA decreased nuclear NFAT approximately 30% compared to the vehicle 
control ( Fig. 5C ).  S ince N FAT i s a C a2+-dependent t ranscription f actor, this dat a 
demonstrates a di rect mechanism l inking the decrease in [Ca2+]i  observed in DCPA-













Figure 5A. DCPA decreases nuclear NFAT levels.  Nuclear extracts from Jurkat cells 
were s timulated a nd ex posed t o 100 µM D CPA at  v arious t ime po ints. A, a  
representative bl ot i ndicating t he bands  t hat r epresent di fferent f orms o f NFAT ( top 
blot).  The bands in the bottom blot are β-actin levels used as a loading and transfer 
control.  B, the ratio of NFAT protein to β -actin protein using densitometry of the bands 






Figure 5B  and 5C . DCPA dec reases nu clear N FAT l evels.  B, t he r atio of  N FAT 
protein to β -actin protein using densitometry of the bands in part A.  C, the ratio the 





Effect of DCPA on Primary Mouse T Cells 
In order to establish that the DCPA-induced attenuation of [Ca2+]i was not unique to the 
Jurkat cell l ine, we assayed the ef fect of  DCPA on [ Ca2+]i levels in pr imary mouse T  
cells.  Splenic T cells were isolated from female BALB/c mice by negative selection and 
magnetic sorting.  The T cells were loaded with fluo-3 and the effect of 100 µM DCPA 
on [ Ca2+]i was as sayed as  des cribed pr eviously.  D CPA e xposure di d n ot af fect the 
anti-CD3 i nduced r elease of  C a2+ from i nternal s tores ( data not  s hown).  H owever, 
there w as a s ignificant dec rease i n [ Ca2+]i following store depl etion and addition of  
external C a2+ (Fig. 6) .  Ther e w ere not  enough dat a poi nts t o as sess t he change i n 
peak [Ca2+]i but the AUC (t=517-616 s) was significantly decreased (16%) in the DCPA 
treated cells (Fig. 6B).  A ltogether, these results demonstrate that the effect of DCPA 









Figure 6. DCPA decreases [Ca2+]i in primary mouse T cells.  Purified mouse splenic 
T cells were loaded with fluo-3.  Anti-CD3 was added simultaneously with 100µM DCPA 
or vehicle control and Ca2+ fluorescence measured.  A t 567 s , the external [Ca2+] was 
raised t o 2. 5 m M w ith C aCl2.  A, a r epresentative ex periment s howing [ Ca2+]i in t he 
presence o f v ehicle c ontrol ( solid l ine) or  100 µM D CPA ( dashed l ine).  B, s tatistical 
analysis of the AUC.  Error bars reflect the ± S.D. from 2 experiments and analysis was 





DCPA i s a w idely u sed her bicide t hat i s heav ily u sed on r ice c rops.  Its r ecent 
registration f or us e o n t urf w ill f urther i ncrease not  onl y i ts us e but  w ill i ncrease t he 
likelihood of human exposure to DCPA.  Currently, workers involved in manufacturing, 
handling or applying DCPA are at greatest r isk of exposure but there have also been 
reports of non-occupational exposure, including a child under the age of 6 (EPA 2006).  
The U nited S tates E nvironmental P rotection A gency ( EPA) c onducted a r isk 
assessment f or w orkers i nvolved i n m ixing, l oading and app lication of  D CPA. Th e 
results from this assessment indicate that workers using maximal protection, including  
closed mixing and loading systems and enclosed cockpit, cabs or trucks, are at risk for 
exposure to  DCPA (EPA 2006).  I n addition, workers entering treated areas 12 hours 
after application were also at risk (EPA 2006).These conclusions emphasize the need 
to investigate the effects of human exposure to DCPA. 
The ef fects of  D CPA i n t he r odent m odel have be en w ell es tablished.  I n a m ouse 
model, exposure to DCPA results in thymic at rophy, depressed NK and m acrophage 
functions, altered cytotoxic T c ell response, and dec reased CD4+ T cells (Barnett and 
Gandy 1989; Zhao,  Schafer et  al . 1995;  Sheil, Frankenberry et  al . 2006;  Ustyugova, 
Frost et  al . 2007)  .  The ef fect of D CPA o n hum an i mmune c ells has  bee n l imited. 
Human m acrophages ex posed t o D CPA p roduce r educed l evels of  TN F-α, reactive 
oxygen species and reactive nitrogen species (Ustyugova, Frost et al. 2007).  Human T 
cells e xposed t o D CPA e xhibit dec reased I L-2 pr oduction an d dec reases bi nding of  
transcription factor AP-1  to DNA (Brundage, Schafer et al. 2004) .  Recently Corsini et 
al examined agr icultural w orkers ex posed t o D CPA and r eported al terations i n 




Since t he s ustained and  el evated i nflux of  C a2+, f ollowing s tore depl etion, i s 
necessary for T c ell activation and pr oliferation, we examined the effects of DCPA on 
[Ca2+]i.  Our ex periments dem onstrate t hat D CPA at tenuates t he i ncreased [ Ca2+]i 
following store depl etion in a  c oncentration d ependent m anner.  A nti-CD3 o r 
thapsigargin induced store depletion in DCPA-exposed Jurkat cells did not  affect IP3-
mediated release of  C a2+ nor t he dep letion of  E R C a2+ stores. H owever, our  
experiments demonstrate that DCPA-exposed Jurkat T cells and mouse splenic T cells 
were able to attenuate the normal elevated [Ca2+]i observed following store depletion.  
As a c onsequence of  t his at tenuation nuclear NFAT l evels and I L-2 production were 
also decreased.  
2-APB is widely us ed as  bot h an i nhibitor and en hancer of  C a2+ influx t hrough 
CRAC c hannels ( Prakriya and  Lew is 2 001; P rakriya and L ewis 2006 ).  Low 
concentrations of 2-APB potentiate Ca2+ influx through CRAC channels following store 
depletion b ut do not  affect IP3-mediated r elease of  Ca2+ from th e E R (Prakriya and  
Lewis 200 1).  We u sed 2 -APB t o f urther el icit t he i nhibitory role o f DCPA in  Ca 2+ 
signaling. At low concentrations of  2 -APB (<5.0 µM) Ca 2+ influx i s enhanced through 
CRAC channels following store depletion.  Jurkat cells exposed to a mixture of 100 µM 
DCPA and 2.5 µM 2-APB abrogated the enhanced Ca2+ influx seen with 2.5 µM 2-APB. 
This data suggests that T cells exposed to DCPA prevent the increased influx of Ca2+ 
seen at  low concentrations of  2 -APB by  inhibiting events surrounding CRAC channel 
activation.   
Both voltage-gated a nd Ca2+-activated pot assium ( K+) channels ar e PM channels 




influx t hrough C RAC c hannels ( Lewis 2 001; P anyi, V arga et  al . 2004;  Q uintana, 
Griesemer et al. 2005).  Alterations in the K+ channel can change the polarization state 
and result in alterations of Ca2+ influx (Panyi, Varga et al. 2004). Depolarization of the 
cell can inhibit Ca2+ influx whereas hyperpolarization increases the driving for force of 
Ca2+ into the cell.   Our experiments indicate that DCPA does not alter the membrane 
potential of T cells (Fig.4) and therefore DCPA is unlikely to affect these channels.  
In T c ells, t he pl asma m embrane C a2+-ATPase ( PMCA) pum p i s c onsidered t he 
primary C a2+ extrusion m echanism.  M odulation of  P MCA ac tivity c an oc cur i n 
response to an influx of Ca2+ through CRAC channels and results in long term stability 
of t he C a2+ signal (Feske, P rakriya et  al . 2005) .  S ince w e ha ve dem onstrated t hat 
DCPA-treated cells attenuate the increase in [Ca2+]i following store depletion it may be 
possible t hat D CPA enhanc es P MCA ac tivity and t hereby r educes t he appar ent 
amount of  c ytosolic Ca2+.  H owever, t his m echanism appear s unl ikely s ince P MCA 
activity would also result in a decrease [Ca2+]i during the initial IP3-mediated release of 
Ca2+ from internal s tores. Fi gures 1A , 2A  and 3A  de monstrate no c hange i n [ Ca2+]i 
during t he i nitial I P3-mediated r elease of  C a2+ from internal s tores i n D CPA-treated 
cells.  
The m itochondria a lso pl ay a n i mportant r ole i n C a2+ homeostasis (Parekh 2003;  
Quintana, Griesemer et al. 2005).  Mitochondria can act as a Ca2+ sink and sequester 
large amounts of Ca2+ quickly and release it slowly after Ca2+ influx subsides (Parekh 
2003).  Expression of a uniporter in the mitochondrial inner membrane and a Na+/Ca2+ 
exchanger allow for Ca2+ uptake and release, respectively (Parekh 2003).  A lterations 




mitochondrial membrane could result in an apparent decrease in Ca2+ influx. Although 
we h ave n ot i nvestigated t he e ffects of  D CPA on  t he m itochondria a ny i ncreased 
function of Ca2+ uptake by the mitochondria would also result in an apparent decrease 
the initial IP3-mediated release of Ca2+ from internal stores, which was not observed in 
DCPA-exposed T cells.   
Our data indicates that DCPA alters Ca2+ homeostasis in human and murine T 
cells. S pecifically, D CPA i s ab le t o at tenuate t he i ncrease i n [ Ca2+]i following s tore 
depletion. The ability of DCPA to abrogate the enhanced Ca2+ influx produced by 2.5 
µM 2 -APB through CRAC channels provides some ev idence t hat DCPA is ac ting on  
mechanisms involved in the activation or regulation of CRAC channels. This decrease 
in [ Ca2+]i has s ignificant dow nstream c onsequences on nuclear N FAT l evels a nd 
secretion o f IL -2. A lthough the exact mechanism by  which DCPA exerts i ts e ffect i s 
unknown it is clear that the decrease in [Ca2+]i results in a functional consequence to 
human T cells.  The data presented here indicates that exposure to DCPA alters [Ca2+]i 
in murine and human Jurkat T c ells and may result in immunosuppression resulting in 
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Each y ear 2  billion pounds of  h erbicide ar e us ed worldwide t o control t he unw anted 
growth of  plants.  I n the United States, over 0.5 bi llion pounds are used, representing 
28% of  worldwide use.  P ropanil (chemical name 3,4-dichloropropionanilide, DCPA) is 
the 17th most commonly used herbicide in the United States and 6-9 million pounds are 
applied a nnually t o 2  m illion ac res of  r ice f ields.  T he i mmunomodulatory ef fects of  
DCPA hav e been well d ocumented but  no dat a i s av ailable on t he ef fects of  i ts 
metabolites.  In mammals, hepatic enzymes metabolize DCPA into 3 major metabolites; 
3,4-dichloroaniline ( DCA), 6 -hydroxy-3,4-dichloroaniline ( 6OH-DCA), a nd N-hydroxy-
3,4-dichloroaniline (NOH-DCA).  W e report for the first time the immunotoxic effects of 
propanil m etabolites on T c ell f unction. J urkat T c ells were ex posed to v arying 
concentrations of  D CPA and i ts m etabolites and as sayed f or v iability, I L-2 s ecretion, 
NFAT ac tivity and  c alcium f lux.  I n add ition, t he f luorine analogs of  D CPA and  D CA 
were i nvestigated t o determine the r elative r ole of c hlorine s ubstituents on T c ell 
immunotoxicity.  As previously reported, Jurkat T cells exposed to DCPA decreased IL-
2 s ecretion i n a  c oncentration a nd c alcium-dependent m anner.  H ere w e r eport t hat 
exposure of Jurkat T cells to DCA also alters IL-2 secretion, NFAT activity and calcium 
influx, similar to DCPA. Interestingly, exposure to 6OH-DCA and NOH-DCA reduces IL-
2 secretion and NFAT activity but has no effect on calcium influx.  When both chlorines 
in DCPA and DCA were substituted with fluorines all effects were abrogated.  Our data 
indicates that metabolites of  DCPA have differential effects on T c ell function and the 






Approximately 5. 3 bi llion po unds of  pes ticides ar e a pplied ann ually a cross t he 
United States and 15 of the top 25 m ost used pesticides are herbicides (Grube 2004).  
Propanil (chemical name 3,4-dichloropropionanilide, DCPA) is a post-emergent contact 
herbicide and i s t he 17 th most us ed h erbicide i n t he U nited States (USEPA 2 006).  
Annual use of DCPA is estimated to be 6 -9 million pounds per year and i s distributed 
over 2 million acres of crop land, primarily rice fields.  Rice plants are able to avoid the 
herbicidal effects of DCPA because they produce acylamidase, an enzyme that cleaves 
the amide bond, resulting in the production of 2 m etabolites, 3,4-dichloroaniline (DCA) 
and pr opionic ac id (Still 1 968). I n m ammals, D CPA c an al so be  m etabolized t o D CA 
and pr opionic ac id v ia ac ylamidases i n t he l iver (McMillan, L eakey et  al . 1990). DC A 
can undergo further biotransformation in the liver to produce the oxidative metabolites, 
N-hydroxy-3,4-dichloroaniline ( NOH-DCA) a nd 6 -hydroxy-3,4-dichloroaniline ( 6OH-
DCA) (Fig.A).  P ropionic ac id is non-toxic and converted to CO2 and water but  l imited 
data is available on the effects of DCA and its oxidative metabolites.  
Workers i nvolved i n manufacturing, ha ndling or  a pplication of  DCPA ar e at  
greatest r isk f or ex posure but  t here hav e al so b een r eports of  non -occupational 
exposure (Pastorelli 1998) .  Numerous in vitro studies hav e r eported t he 
immunomodulatory effects of exposure to DCPA (reviewed in (Salazar, Ustyugova et al. 
2008)).  Exposure to D CPA alters m acrophage phagocytic activity an d c ytokine 
production as  w ell a s t he l ytic function of  C D8+ T cells after s econdary stimulation 
(Sheil, Frankenberry et al. 2006; Ustyugova, Frost et al. 2007; Salazar, Ustyugova et al. 
2008).  O ther i mmunotoxic ef fects i nclude dec reased nat ural k iller ( NK) c ell f unction, 




Rosa et al. 2005).  Recent studies from our lab demonstrate that exposure of Jurkat T 
cells to DCPA results in a concentration dependent decrease in IL-2 production that is 
mediated by al terations i n N FAT t ranslocation and c alcium hom eostasis (Lewis, 
Brundage et al. 2008).   
Limited data is available on t he toxic effects of DCA, NOH-DCA and 6OH-DCA.  
It has been reported that DCA and NOH-DCA are toxic to the bladder, liver and kidney 
of ra ts (Valentovic, Yahia et  a l. 1997) .  D CA c an also a lter t he m ale reproductive 
system, binds weakly to the androgen receptor and m ay act as an endocrine disruptor 
(Bauer, Me yer et  al . 1998;  Zha ng and L in 2009) .  M ice e xposed t o m olar equi valent 
concentrations of DCPA or DCA have decreased natural killer (NK) cell activity (Barnett 
and Gandy 1989). However, some studies suggest that DCPA may be more toxic than 
DCA (Zhao, Schafer et al. 1995; Malerba, Castoldi et al. 2002).  C orsini et al reported 
that workers exposed to DCPA had several alterations in immune parameters (Corsini, 
Codeca et al. 2007).  Agricultural workers exposed to DCPA had increased plasma IgG1 
and IL-6 production in whole blood assays and decreased IL-10 and interferon-γ (IFN-γ) 
when compared to control subjects. In vitro assays demonstrated similar results and at 
molar equi valent c oncentrations, bot h D CPA and D CA i nhibited I L-10 and I FN-γ 
production i n enr iched C D4+CD8+ s amples.  I n addi tion, al terations i n c alcium 
homeostasis and c ytokine pr oduction w ere obs erved i n a nti-CD3 a nd PHA -stimulated 
peripheral blood mononuclear cells, suggesting that human T cells may be sensitive to 
the effects of DCPA. 
Using Jurkat T c ells we i nvestigated t he ef fects of  DCA, NOH-DCA, and 6OH-




containing pesticides are a c ommon c lass of  pes ticides and 4 5% of  al l pes ticides 
introduced into the market af ter 1989 c ontain a  chlorine-carbon bond (Jeschke 2004).  
The add ition of  c hlorine t o m any c hemical compounds c an i ncrease i ts ac tivity w ith 
negative biological c onsequences.  D DT i s a well k nown or ganochlorine pes ticide 
whose effects are mediated through the presence and positioning of chlorines (Crinnion 
2009). Although al terations in calcium-dependent s ignaling events have been reported 
in T c ells exposed t o D CPA, the ef fects of  t he m etabolites produced in h umans ar e 
unknown.  We report that exposure to DCA alters IL-2 secretion in a calcium-dependent 
manner but at higher concentrations than that observed with DCPA.  In addition, NOH-
DCA and 6OH-DCA appear more toxic to T cells than DCPA and DCA and inhibit IL-2 
secretion i n a c alcium-independent m anner.  Fi nally, t he s ubstitution of  f luorines for 
chlorines results in an abrogation of all investigated effects in Jurkat T cells.  This is the 
first r eported s tudy on t he ef fects of  D CPA m etabolites on T  c ells and  a dvances our 






Figure 1A DCPA metabolic pathway and structures and in mammals 
 
 




MATERIALS AND METHODS 
Cell lines and reagents 
Experiments w ere per formed us ing t he hum an T c ell l eukemia cell l ine, J urkat 
clone E6-1, obtained from the ATCC (American Tissue Culture Collection, Manassas, 
VA).  J urkat cells were maintained in complete Roswell Park Memorial Institute (RPMI 
1640) ( Mediatech I nc., H erndon, V A) s upplemented w ith 10%  heat  i nactivated f etal 
bovine s erum ( v/v) ( FBS) ( Hyclone I nc. Logan , U T), 100 un its/ml peni cillin 
(BioWhittaker, W alkersville, M D), 100 µg/ml s treptomycin (B io W hittaker), 2 0 m M 
glutamine ( BioWhittaker) and 50  µM 2-mercaptoethanol (Sigma, St. Louis, MO).  The 
cultures were kept at 37°C in 5% CO2. 
Stock s olutions of  3,4-dichloropropionanilde ( DCPA) (ChemServices, W est 
Chester, P A), 3 ,4-dichloroaniline ( DCA) ( Chem Se rvices), 3,4-difluoropropionanilide 
(DFPA), and 3,4-difluoroaniline (DFA) (Sigma) were diluted in absolute ethanol (AAPER 
Alcohol and Chemical Company, Shelbyville, KY).  Vehicle samples were t reated with 
an equi valent c oncentration ( 0.1% v /v) of  ethanol.  S tock s olutions of  N -hydroxy-3,4-
dichloroaniline ( NOH-DCA) a nd 6-hydroxy-3,4-dichloroaniline ( 6OH-DCA) ( a gener ous 
gift f rom G. Rankin) were di luted in dimethyl sulphoxide (DMSO) (Sigma) and v ehicle 
samples were treated with an equivalent concentration (0.1% v/v) of DMSO.  
Synthesis of DFPA and NOH-DCA 
3,4-Difluoropropionanilide ( DFPA) w as s ynthesized f rom 3, 4-difluoroaniline 
(DFA) (S igma-Aldrich, M ilwaukee, WI).  Two grams of  propanoic ac id (Sigma-Aldrich) 
was added to 1g of  DFA and heated to 100°C for 1 h followed by add ition of  5 m l o f 




cooled to room temperature, filtered through a sintered glass funnel, washed with water 
and dr ied in vacuo resulting in 1. 26g of  D FPA.  The c rude D FPA w as t hen r e-
crystallized from a 1:1 water and ethanol solution.  
N-hydroxy-3,4-dichloroaniline ( NOH-DCA) w as s ynthesized by  m ethods 
described by Lerman (Lerman, Weinstock-Rosin et al. 2004).  In the presence of nitric 
acid, dichloromethane and t etra-n-butylammonium bromide (TBAB), 3,4-dichlorophenol 
was converted to 4,5-dichloro-2-nitrophenol, which was analyzed using NMR  and mass 
spectroscopy and was found to be in agreement with others (Lerman, Weinstock-Rosin 
et al. 2004).  Ethanol (100%) was added to 0.32 g 4,5-dichloro-2-nitrophenol  and 20 mg 
platinum dioxide and hydrogenated  ( 30-50 psi) on a Parr shaker for 1 h.  The m ixture 
was filtered through celite and concentrated in vacuo to yield NOH-DCA.   
Production and pur ity of  DFPA, NOH-DCA and the intermediate, 4,5-dichloro-2-
nitrophenol w ere v erified us ing N MR s pectra f rom a V arian U nity-300 N MR 
spectrometer (Palo Alto, CA) and exact mass data was obtained using a Thermo-Fisher 
LTQ-FTICR and were in agreement with previously reported analytical data (Lok, Leone 
et al. 1996; Lerman, Weinstock-Rosin et al. 2004). 
Viability assays 
Viability assays were performed for DCPA, DCA, NOH-DCA, 6OH-DCA, DFPA, 
DFA using 7 -AAD ( 7-amino-actinomycin) ( BD Pharmingen, San Diego, C A) an d 
following the manufacturer’s protocol.  Briefly, 1.0 x 106 Jurkat cells were treated with or 
without varying concentrations of DCPA, DCA, NOH-DCA, 6OH-DCA, DFPA, DFA, and 
including ethanol and DMSO vehicle controls and incubated at 37°C in 5% CO2 for 24 




for 20 m in i n t he dark.   C ells were then w ashed and r esuspended i n 0. 4% 
paraformaldehyde and analyzed by flow cytometry. Emission was detected in the FL-3 
channel ( >650nm) us ing a F ACSCalibur f lowcytometer ( Becton D ickson, Fr anklin 
Lakes, NJ).  
Calcium Fluorescence Measurements 
Jurkat c ells w ere loaded w ith t he c alcium-indicator dye f luo-3 AM ( Invitrogen, 
Carlsbad, CA) as previously described (Grynkiewicz, Poenie et  a l. 1985). Briefly, cells 
were harvested and r e-suspended to a concentration of 5 × 106 cells/ml and incubated 
for 30 m in (37°C in 5% CO2) in complete RPMI media (1.5% FBS, v/v) containing 0.1 
µM f luo-3 AM  i n t he pr esence of  0. 02% pl uronic F -127 ( Invitrogen) and 2. 5 m M 
probenecid (Sigma).  Cells were washed twice in Ca2+ and Mg2+-free Hanks Balanced 
Salt Solution (HBSS) (Mediatech Inc.) containing 10 mM N-(2-hydroxyethyl)-piperazine-
N’-2-ethanesulfonic acid ( HEPES), pH  7. 4, 2%  FBS and  2. 5 m M pr obenecid, 
resuspended t o a c oncentration of  1 × 106 cells/ml and i ncubated 30 m in at  r oom 
temperature.  S ince t he addi tion of  2%  FB S i s es sential f or c ell v iability, the m edia 
contains a  nom inal concentration of  C a2+ (2.5 µM).  S amples w ere k ept at  r oom 
temperature and protected from light until ready for analysis.  For each sample, 2 × 106 
cells were placed in a quartz cuvette and t he f luorescence was measured using a P TI 
QM-2000-4 s pectrofluorometer (Photon Te chnology I nternational ( PTI), B irmingham, 
NJ) w ith c onstant s tirring.  The f luorescence of  t he f luo-3 dy e w as m easured w ith 
excitation at 490 nm  and em ission at  525 nm.  The f luorescence was m easured an d 
digitized at 1 H z us ing t he s oftware pr ogram Fel iX 1.42b ( PTI).  D ata poi nts w ere 




metabolites or  anal ogs and 2 µ M t hapsigargin ( Sigma) or  2 µM  t hapsigargin al one.  
Reagents were added af ter baseline data was collected for 45 s econds. Fol lowing the 
return of  fluorescence t o bac kground l evels, 2. 5mM CaCl2 (Sigma) w as added t o t he 
media.  A ddition of 200 µM ionomycin (Sigma) ensured even loading of the cells.  C ell 
membranes were lysed with 0.1% (v/v) Triton X-100 (Fisher Scientific, Hampton, NH) to 
measure t he m aximum f luorescence ( Fmax) par ameter f or c alculation of  [ Ca2+]i and t o 
monitor compartmentalization of the dye.  To chelate the free Ca2+ to a nominally Ca2+-
free level (Fmin), 50mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid 
tetrasodium salt (EGTA), pH 7.5 (Sigma) was added to the cuvette.  
Fluorescence values were converted to [Ca2+]i using the following equation:  
free[Ca2+]i = KD[(F-Fmin)/(Fmax-F)], 
where K D (360 nM ) i s t he di ssociation c onstant of  t he Fl uo-3/Ca2+ complex, F i s t he 
measured f luorescence intensity, F min is t he m inimum f luorescence at  very low [Ca2+]i 
(fluorescence after the addition of 50 mM EGTA) and Fmax is the fluorescence measured 
at high [Ca2+]i (fluorescence after the addition of Triton X-100) (Grynkiewicz, Poenie et 
al. 1985).  The bac kground fluorescence obtained from unloaded cells over a 3 m inute 
time period was subtracted from all data points before [Ca2+]i was calculated. 
Measurement of IL-2 Production 
 Jurkat cells were cultured in complete RPMI media at 5 × 105 cells/well in 48-well plates 
(Costar, C orning, N Y) c oated w ith m ouse ant i-human C D3 a ntibody ( 10 µg/ ml)(BD 
BioSciences, San Diego, CA).  Cells were treated with varying concentrations of DCPA, 
DCA, DFPA, DFA, NOH-DCA, 6OH-DCA, ethanol or DMSO vehicle control.  Cells were 




Cells we re incubated at  37 °C i n 5 % CO 2 for 24 h af ter w hich s upernatants w ere 
collected a nd pl aced at -20°C.  I L-2 pr oduction w as determined us ing t he s andwich 
ELISA method and following the manufacturer’s protocol (BD PharMingen).  All cultures 
and ELISA analyses were per formed in t riplicate and the experiment was repeated a t 
minimum of three times. 
Transfections and Luciferase assay 
Jurkat cells were plated in RPMI media with 1.5% FBS at 6 x 105 cells/well in a 6 -well 
plate ( Costar).  For  eac h well, 750 ng of pN FAT-luc ( firefly l uciferase pl asmid) 
(Stratagene) and 10ng pRL-TK (Renilla luciferase plasmid) (Promega) were transfected 
with 1ul L ipofectamine 2000 ( Invitrogen).  C ells were incubated for 5 h at  37°C in 5% 
CO2 and media was replaced with complete RPMI +10% FBS and incubated over night 
at 37° C i n 5%  C O2.  Fol lowing t ransfection, c ells w ere t reated w ith v arying 
concentrations of DCPA, DCA, DFPA, DFA, NOH-DCA, 6OH-DCA, ethanol or DMSO or 
left unt reated an d s timulated w ith 10ng/ ml P MA a nd 1ug/ ml A23187.  C ells w ere 
incubated for 4 h at  37°C in 5% CO2, centrifuged, lysed and stored at -70°C until ready 
for anal ysis.  N FAT activity w as det ermined us ing t he D ual L uciferase Assay K it and 
following the manufacturer’s protocol (Promega).  B riefly, 25ul of sample was added to 
100ul of  L uciferase A ssay R eagent I I and t he f irefly l uciferase ac tivity m easured.  
Addition of Stop & Glo quenched the f irefly luminescence and provides a substrate for 
the Renilla luciferase activity.  Lum inescence was detected using a B erthold Lumat LB 
9507 (Oak Ridge, TN). NFAT-firefly luciferase transfection efficiency was normalized to 
the Renilla luciferase activity and the average fold change was reported. All luciferase 





All data were analyzed using MS Excel 2007 (Redmond, WA) and Sigma Stat 3.1 (Port 
Richmond, C A).  A NOVA w ith a S tudent-Newman Keuls p ost hoc t est w as us ed t o 






Hydroxy metabolites of DCPA are more cytotoxic than its parent. 
In m ammals, m etabolism of  D CPA r esults i n t he hy drolysis of t he am ide s ide 
chain an d pr oduction of  t he 3 ,4-DCA w ith f urther b iotransformation r esulting i n t he 
formation of  6O H-DCA a nd NOH-DCA.  To as sess t he c ytotoxicity of  D CPA and  i ts 
metabolites on J urkat T cells, v iability and pr oliferation assays were conducted over a 
range of  concentrations.  For  cells exposed to DCPA, DCA, DFPA, and DFA, ethanol 
(0.1%v/v) was used as a v ehicle control and D MSO was used as a v ehicle control for 
6OH-DCA and NOH-DCA.  Jurkat T c ells were treated or left untreated, loaded with 7-
AAD and viability was assessed after 24 hours (Fig.2).  The viability of cells treated with 
increasing concentrations of  D CPA u p t o 100µM di d not  dec rease viability (Fig.2A).  
Treatment with 200µM DCPA decreases viability by approximately 14.6% (Fig.2A) and 
subsequent studies were conducted using a m aximum concentration of 100µM DCPA.  
DCA a ppeared t o be l ess t oxic and c oncentrations up t o 200 µM w ere not  c ytotoxic 
(Fig.2B).  H owever, J urkat T c ells were more s ensitive t o t he hy droxylated D CA 
metabolites and c ytoxicity was observed at  100µM for both 6OH-DCA and NOH-DCA 
(Fig.2C and 2D).  This concentration was excluded for both 6OH-DCA and NOH-DCA in 
all s ubsequent as says.  P roliferation as says w ere al so per formed and pr oliferation of  
Jurkat T c ells was inhibited only at those concentrations that were also cytotoxic (data 







Figure 2A and 2B Cytotoxic effects of DCPA and DCA 
Jurkat T c ells were treated with or without varying concentrations of A) DCPA,B) DCA, 
or their vehicle control, ethanol for 24 h.   Cells were stained with 7-AAD to determine 
viability.  Re sults using f low c ytometry are r epresentative of  3 ex periments eac h 






Figure 2C and 2D Cytotoxic effects of 6OH-DCA and NOH-DCA 
Jurkat T c ells were treated with or without varying concentrations of, C) 6OH-DCA, D) 
NOH-DCA, or their vehicle control DMSO for 24 h.   C ells were s tained with 7-AAD to 
determine v iability using f low cytometry.  R esults ar e r epresentative of  3 ex periments 




DCPA and its metabolites decrease IL-2 secretion. 
 
We have previously reported that exposure to DCPA decreases IL-2 production 
in Jurkat T cells in a calcium-dependent manner (Lewis 2008). IL-2 is an important early 
cytokine produced by T cells and is critical for the activation and proliferation of several 
immune c ells, i ncluding N K c ells, T c ells a nd B  c ells.  To det ermine i f ex posure t o 
metabolites of  D CPA alter I L-2 p roduction, J urkat T c ells w ere t reated ov er r ange of  
concentrations with or without vehicle controls (DMSO for the hydroxylated metabolites 
and ethanol for al l others) and s timulated with ant i-CD3 and ant i-CD28.  A fter 24 h i n 
culture, IL-2 secretion levels in the supernatant were assessed using an ELISA.  DCPA 
decreased I L-2 s ecretion i n a c oncentration-dependent m anner w ith s ignificant 
decreases observed at  25µM, 50µM, and 1 00µM DCPA and r epresented a 20%, 48% 
and 74% decrease in IL-2 production, respectively (Fig. 3A).  This data is an agreement 
with previously reported decreases of IL-2 in response to DCPA treatment.  
Metabolism of D CPA i s r eported t o oc cur i n t he l iver t hrough t he ac tion o f 
acylamidases w hich c leave t he amide s ide c hain r esulting in t he pr oduction of  D CA 
(McMillan). Several studies have reported detectable levels of DCA in blood and urine in 
DCPA-exposed individual. When Jurkat cells are exposed to increasing concentrations 
of DCA ( 25-200µM), c oncentration-dependent dec reases i n I L-2 s ecretion ar e al so 
observed (Fig. 3B).  At a concentration of 50µM decreases are observed but statistically 
significant decreases are only observed at 100µM and 200µM DCA (Fig. 3B).  Exposure 
to 50µM, 100µM and 200µM DCA resulted in a 10% , 45% and 7 8% decrease in IL-2, 
respectively. These results suggest that, in T cells, DCPA is more potent inhibitor of IL-2 




In m ammals, hy droxylation of  DCA t o 6 OH-DCA a nd NO H-DCA occurs i n t he 
liver and both oxidative metabolites are capable of  converting oxy-hemoglobin (Hb) to 
met-Hb.  I n J urkat T  c ells, NOH-DCA an d 6O H-DCA ar e c ytotoxic at  10 0µM s o t o 
assess their effects on IL-2 secretion lower concentrations were evaluated.  Both 6OH-
DCA a nd NO H-DCA dec reased I L-2 s ecretion how ever N OH-DCA i s a more pot ent 
inhibitor of IL -2 s ecretion (Fig. 3C and 3D ).  6O H-DCA dec reased I L-2 pr oduction by 
30% at  t he hi ghest c oncentration ( 50µM) w hereas 25µM  and 50µM  N OH-DCA 
decreased IL-2 secretion by  51% and 90% , respectively. No change in IL-2 secretion 
was observed i n cells t reated w ith 5uM NOH-DCA.  T his data indicates that Jurkat T  







Figure 3A and 3B DCPA and DCA inhibit IL-2 secretion 
Jurkat T cells were treated with or without varying concentrations of A) DCPA, B) DCA, 
and stimulated with ant i-CD3 and ant i-CD28 for 24h.   Supernatants were analyzed by  
ELISA and results are representative of three separate experiments.  E rror bars reflect 
± SD and asterisks (*) indicate statistically significant results, p<0.05 using ANOVA with 







Figure 3C and 3D NOH-DCA and 6OH-DCA inhibit IL-2 secretion 
Jurkat T c ells were t reated with or without varying concentrations of  C) 6OH-DCA, D) 
NOH-DCA and s timulated w ith a nti-CD3 an d ant i-CD28 for 24 h.   S upernatants were 
analyzed by ELISA and results are representative of three separate experiments.  Error 
bars reflect ± SD and as terisks (*) indicate statistically significant results, p<0.05 using 




DCPA and its metabolites alter NFAT activity 
 
 In T c ells, optimal transcription of the IL-2 gene requires coordinated binding of 
three t ranscription f actors; N FAT ( nuclear f actor of  ac tivated T c ells), N F-kB ( nuclear 
factor kappaB) and AP-1 (activator protein-1).  We have previously reported that DCPA-
exposed J urkat c ells hav e dec reased A P-1 D NA bi nding ab ility, dec reased c -jun 
phosphorylation and d ecreased nuclear NFAT levels. To f urther understand the effects 
of DCPA and its metabolites on IL-2 secretion Jurkat T cells were co-transfected with a 
NFAT l uciferase pl asmid  ( pNFAT-luc) an d a R enilla l uciferase pl asmid ( pRL-TK), to  
control f or t ransfection ef ficiencies.  I n r esting T cells, N FAT i s l ocalized t o t he 
cytoplasm in a phos phorylated state and up on stimulation becomes de-phosphorylated 
by t he c alcium-dependent ph osphatase, calcineurin.  D ephosphorylation of  N FAT 
exposes a  nuc lear l ocalization sequence f acilitating i ts t ranslocation i nto t he nuc leus 
and binding to the promoter region of the targeted gene.  I n this system, stimulation of 
Jurkat cells leads t o t he de-phosphorylation of  endogenous N FAT that binds to th e 
NFAT DNA binding sites on t he pN FAT-luc pl asmid which controls expression of  t he 
firefly luciferase.  In cells exposed to 25-100µM DCPA there is a significant decrease in 
NFAT activity (Fig 4A), w ith a 37 %, 63% and 87%  dec rease i n NFAT ac tivity i n cells 
treated with 25µM, 50µM and 100µM DCPA, respectively.  Similarly, cells t reated with 
DCA a lso hav e dec reased NF AT a ctivity at t hose c oncentrations t hat r esulted i n 
decreased I L-2 s ecretion ( Fig 3B).  C ells e xposed t o 100 µM and 2 00µM D CA 
statistically decreased NFAT activity levels by 66 and 18% , respectively (Fig 4B). 6OH-
DCA-treated c ells had a 30% decrease i n N FAT ac tivity at  5 0µM but  no  c hange at  




50µM, respectively (Fig.4D).  Although 50µM NOH-DCA inhibited IL-2 secretion by 90% 
NFAT activity is only decreased by 47%, whereas 100µM DCPA decreased IL-2 by 74% 
with an 87% decrease in NFAT activity.  This data suggests that NOH-DCA may inhibit 
IL-2 thorough an alternate mechanism than DCPA.  In all experiments, cells treated with 
cyclosporin, an i nhibitor of  N FAT t hat pr events dep hosphorylation, pr oduced s imilar 









Figure 4A DCPA alters NFAT activity 
Jurkat T cells were co-transfected with a f irefly luciferase-NFAT reporter plasmid and a 
Renilla luciferase plasmid to control for tranfection efficiency. Cells were treated with or 
without varying concentrations of DCPA or vehicle control and stimulated with PMA and 
A23187 for 5 h.   Unstimulated and cyclosporin treated cells were included as controls. 
Cell l ysates w ere anal yzed f or l uciferase activity and nor malized t o R enilla ac tivity.  
Results ar e r epresentative of  at  l east 2 ex periments eac h pe rformed i n t riplicate.  
Asterisks ( *) in dicate s tatistically s ignificant r esults, p <0.05 u sing ANOVA with a 







Figure 4B DCA alters NFAT activity 
Jurkat T cells were co-transfected with a f irefly luciferase-NFAT reporter plasmid and a 
Renilla luciferase plasmid to control for tranfection efficiency. Cells were treated with or 
without varying concentrations of DCA or vehicle control and s timulated with PMA and 
A23187 for 5 h.   Unstimulated and cyclosporin treated cells were included as controls. 
Cell l ysates w ere anal yzed f or l uciferase activity and nor malized t o R enilla ac tivity.  
Results ar e r epresentative of  at  l east 2 ex periments eac h pe rformed i n t riplicate.  
Asterisks ( *) in dicate s tatistically s ignificant r esults, p <0.05 u sing ANOVA with a 








Figure 4C. 6OH-DCA alters NFAT activity. 
Jurkat T cells were co-transfected with a f irefly luciferase-NFAT reporter plasmid and a 
Renilla luciferase plasmid to control for tranfection efficiency. Cells were treated with or 
without v arying c oncentrations 6O H-DCA or vehicle c ontrol and s timulated with PM A 
and A 23187 f or 5 h.   U nstimulated and cyclosporin t reated c ells w ere i ncluded as  
controls. C ell l ysates were anal yzed f or l uciferase ac tivity and nor malized t o R enilla 
activity.  R esults ar e r epresentative of  at  l east 2 ex periments eac h pe rformed i n 
triplicate.  Asterisks (*) indicate statistically significant results, p<0.05 using ANOVA with 








Figure 4D. NOH-DCA alters NFAT activity 
Jurkat T cells were co-transfected with a f irefly luciferase-NFAT reporter plasmid and a 
Renilla luciferase plasmid to control for tranfection efficiency. Cells were treated with or 
without varying concentrations of NOH-DCA or vehicle control and stimulated with PMA 
and A 23187 f or 5 h.   U nstimulated and cyclosporin t reated c ells w ere i ncluded as  
controls. C ell l ysates were anal yzed f or l uciferase ac tivity and nor malized t o R enilla 
activity.  R esults ar e r epresentative of  at  l east 2 ex periments eac h pe rformed i n 
triplicate.  Asterisks (*) indicate statistically significant results, p<0.05 using ANOVA with 





DCPA and its metabolites have differential effects on Ca homeostasis. 
It has been previously reported that exposure of Jurkat T cells to DCPA results in 
decreased intracellular calcium influx following ER Ca store depletion.  To e xamine the 
effect of DCPA metabolites on calcium homeostasis, Jurkat T c ells were loaded with a 
calcium-sensitive dye and changes in intracellular calcium were monitored over time.  At 
the start of these experiments, the extracellular media is essential Ca-free and depletion 
of ER Ca  s tores wi th t hapsigargin, an i nhibitor of  t he S ERCA ( Sarco/endoplasmic 
reticulum Ca ATPase)  pum p, results i n a  small, t ransient i ncrease i n i ntracellular Ca 
(Fig.5).  A ddition of 2mM Ca to the media results in a large and sustained increase in 
intracellular C a t hat re flects s tore-operated c alcium i nflux ( Fig 5) .  J urkat T c ells 
exposed to DCPA decrease calcium influx following store depletion in a  concentration 
dependent manner (Fig 5A).  A t concentrations of 100µM and 2 00µM DCA, decreases 
in intracellular calcium are also observed (Fig 5B).  I t should be noted that DCPA and 
DCA-treated c ells do not  al ter t he t ransient i ncrease i n i ntracellular c alcium obs erved 
when ER calcium s tores are depleted.  I nterestingly, cells t reated w ith 6OH-DCA and 
NOH-DCA did not inhibit ER calcium store depletion or calcium influx (Fig 5C and 5D).  
This dat a supports t he c onclusion t hat hy droxylated m etabolites al ter I L-2 s ecretion 







Figure 5A DCPA alters calcium influx  
Jurkat T c ells were l oaded with t he c alcium-sensitive dy e, fluo-3, and t reated w ith or  
without v arying c oncentrations of  D CPA or v ehicle c ontrol I mmediately f ollowing 
addition of  t reatment, 2µM  t hapsigargin w as added to depl ete C a s tores.  W hen 
fluorescence r eturned t o bas eline 2 mM Ca Cl2 was a dded and t he ef fect on  C a i nflux 






Figure 5B DCA alters calcium influx 
Jurkat T c ells were l oaded with t he c alcium-sensitive dy e, fluo-3, and t reated w ith or 
without varying concentrations of DCA or vehicle control.  Immediately following addition 
of t reatment, 2µM  thapsigargin w as added  t o depl ete C a s tores.  W hen f luorescence 
returned to baseline 2mM CaCl2 was added and t he effect on C a influx was recorded. 






Figure 5C 6OH-DCA does not alter intracellular calcium concentrations 
Jurkat T c ells were l oaded with t he c alcium-sensitive dy e, fluo-3, and t reated w ith or  
without v arying c oncentrations o f 60H-DCA or  v ehicle c ontrol. Immediately f ollowing 
addition of  t reatment, 2µM  t hapsigargin w as added to depl ete C a s tores.  W hen 
fluorescence r eturned t o bas eline 2m M C aCl2 was a dded and t he ef fect on  C a i nflux 







Figure 5D NOH-DCA does not alter intracellular calcium concentrations 
 Jurkat T c ells were l oaded w ith t he calcium-sensitive dye, fluo-3, and t reated w ith or  
without varying concentrations of  NOH-DCA or vehicle control.  Immediately following 
addition of  t reatment, 2µM  t hapsigargin w as added to depl ete C a s tores.  W hen 
fluorescence r eturned t o bas eline 2 mM Ca Cl2 was a dded and t he ef fect on  C a i nflux 





Chlorine substituents play a role in the immunotoxic effects of DCPA 
To assess the role that chlorines, in the 3 and 4 positions on DCPA, may have on 
the immunotoxic effects in T cells, we synthesized the fluorine analogs of DCPA, DFPA 
(see materials and methods) and used DFA, a commercially available fluorine analog of 
DCA.  Concentrations up to 400µM of both DFPA and DFA were not cytotoxic to Jurkat 
T cells (Fig 6A and 6 B).  P roliferation assays were also conducted and no changes in 
proliferation af ter 24  hour s w ere obs erved at  c oncentration up t o 400 µM  ( data n ot 
shown).  To det ermine t he ef fect of  D FPA and D FA o n I L-2 s ecretion, J urkat T  cells 
were s timulated with ant i-CD3 a nd ant i-CD28 and I L-2 w as m easured as  des cribed 
above.  No changes in IL-2 secretion were detected when Jurkat cells were exposed to 
DFPA or DF A wit h increasing concentrations up t o 400µM ( Fig 6C  a nd 6D).  Thes e 
results indicate the presence of chlorine as the 3 and 4 positions play an important role 
in t he i nhibiting I L-2 s ecretion i n D CPA a nd D CA e xposed T cells.  To c onfirm t he 
apparent i nert ef fects of  f luorine s ubstitution, N FAT activity an d C a i nflux w ere al so 
examined as described above.  Consistent with the IL-2 secretion data, Jurkat T c ells 
exposed to DFPA and DFA did not alter NFAT activity or Ca homeostasis (Fig 6E-6H).  
This dat a provides c lear ev idence t hat t he i mmunotoxic ef fects of  D CPA and i ts 
metabolites, on T cells, can be attributed, in large part, to the presence and l ocation of 









Figure 6A and 6B Cytotoxic effects of DFPA and DFA 
Jurkat T cells were treated with or without varying concentrations of A) DFPA or B) DFA 
and vehicle control for 24h.   C ells were s tained w ith 7-AAD to determine v iability and 
analyzed w ith f low cytometry.  Results ar e r epresentative of  3 ex periments eac h 








Figure 6C and 6D DFPA and DFA do not inhibit IL-2 secretion 
Jurkat T c ells w ere t reated w ith or  w ithout varying c oncentrations of  A ) D FPA or  B) 
DFA, and vehicle c ontrol and  s timulated w ith ant i-CD3 and  ant i-CD28 f or 24 h.  
Supernatants w ere c ollected an d anal yzed by  E LISA.  Results ar e r epresentative of  





Figure 6E and 6F DFPA and DFA DCPA do not alter NFAT activity 
Jurkat T cells were co-transfected with a f irefly luciferase-NFAT reporter plasmid and a 
Renilla luciferase plasmid to control for tranfection efficiency. Cells were treated with or 
without varying concentrations of E) DFPA or F) DFA and vehicle control and stimulated 
with P MA and A 23187 f or 5 h.   U nstimulated and  c yclosporin t reated cells w ere 
included as controls. Cell lysates were analyzed for luciferase activity and normalized to 







Figure 6G and 6H DFPA and DFA do not alter intracellular calcium concentrations 
Jurkat T c ells were l oaded with t he c alcium-sensitive dy e, fluo-3, and t reated w ith or  
without v arying c oncentrations of  G ) DFPA, H)  DF A a nd vehicle c ontrol. 2µM 
thapsigargin was added to deplete Ca stores.  When fluorescence returned to baseline 
2mM Ca Cl2 was added and t he ef fect on C a i nflux w as r ecorded. R esults ar e 





In t he U nited S tates, agr icultural us e of  her bicides r epresents 58%  of  t otal 
pesticide use and ap proximately 2 bi llion pounds are appl ied to crop f ields every year 
(Grube 2004). DCPA is a commonly used herbicide in the United States and is used on 
50-80% of  al l r ice c rops f or c ontrol agai nst broadleaf and gr assy pl ants.  The t oxic 
effects of  DCPA on the i mmune s ystem hav e bee n w ell doc umented (reviewed in  
(Salazar, U styugova et  al . 200 8).  In m ouse m odels, in vivo and in vitro exposure t o 
DCPA decreases the phagocytic abi lity of  macrophages and i ts ability to produce IL-6 
and TNF-α when stimulated with LPS (Xie, Schafer et al. 1997; Xie, Schafer et al. 1997; 
Frost, Neeley et al. 2001; Ustyugova, Frost et al. 2007). Primary stimulation of CD8+ T 
cells exposed to DCPA is not  af fected but  the secondary response, in the absence of  
further ex posure t o D CPA, abr ogates l ytic ac tivity (Barnett and G andy 1989;  S heil, 
Frankenberry et al. 2006).  I n human Jurkat T c ells, DCPA decreases IL-2 protein and 
mRNA l evels as  w ell as  t he bi nding ability of  t he t ranscription f actor A P-1 ( activator 
protein-1) and t he pr otein l evels and phos phorylation of  c -jun (Zhao, S chafer et  al . 
1999; B rundage, S chafer et  al . 2004) .  Th e dec reases i n I L-2 secretion o bserved i n 
DCPA-treated T c ells ar e m ediated by  al terations i n N FAT t ranslocation an d c alcium 
homeostasis (Lewis, Brundage et al. 2008).  Although the immunotoxic effects of DCPA 
are well documented little is known about the effects of its metabolites.    
In mammals, DCPA is metabolized in the l iver by acylamidases resulting in the 
production of DCA which can be hydroxylated to form 6OH-DCA and NOH-DCA (Fig.1).  
Exposure t o D CA c an oc cur i n s everal w ays, as  br eakdown pr oducts of  DCPA and  
other her bicide s uch as l inuron and di uron and al so t hrough t he m anufacturing of  




an es timated ha lf l ife of  3.2 hou rs and i s quickly metabolized into DCA which can be  
detected i n t he ur ine and bl ood of  oc cupationally and non -occupationally e xposed 
humans (Wittke, Hajimiragha et al. 2001; Turci, Barisano et al. 2006; Roberts, Heilmair 
et al. 2009). 
 Limited da ta i s av ailable on t he i mmunotoxic effects of D CA bu t B arnett et al 
reported t hat m olar e quivalent c oncentrations of  D CA and  D CPA dec reased natural 
killer (NK) cell activity and increased spleen weight (Barnett, Gandy et al. 1992).  NOH-
DCA and 6OH-DCA are reactive metabolites that have been studied for their effects on 
erythrocytes (Singleton and  M urphy 197 3). B oth NOH-DCA an d 6O H-DCA c an b ind 
hemoglobin leading to methemoglobinemia, a s erious medical condition that results in 
the f ormation of  methemoglobin adducts t hat do not  bind or  t ransport oxygen.  N OH-
DCA has also be en reported as  a nephr otoxicant an d c an i nduce hem olytic anem ia 
(McMillan, Bradshaw et al . 1991; Valentovic, Ball et  al. 2001) .  No data exists on t he 
immunotoxic effects of NOH-DCA and 6OH-DCA.   
Studies o n ex posure and t he ef fects of  D CPA in hu man subjects ar e limited.  
Richards et al measured ai r l evels of  D CPA in f arms adj acent t o r ice f ields and 
determined t hat i ndividuals living near  r ice f ields are at  r isk f or ex posure t o D CPA 
(Richards, McClure et al. 2001).  Accompanying this study, McClure et al reported that 
individuals living in areas sampled by Richards et al did not appear to be at higher risk 
for al tered i mmune f unctions (McClure, H elm et  a l. 2001) .  A lthough i ndividuals 
surrounding rice f ields may not be at r isk, there is evidence to suggest that workers in 
the agr icultural and m anufacturing s ectors ar e at  risk.  Corsini et al examined 




Codeca et  al . 20 07).  D CA was r eadily det ected i n t he u rine of  w orkers at  
concentrations up t o 332ng/ml.  W hole blood assays of the workers revealed that cells 
stimulated with PHA had decreased IL-10 and IFN-γ production.  In addition, Pastorelli 
et al  r eport t hat D CA-Hb adduc ts ar e det ectable i n a gricultural workers ex posed t o 
DCPA for as long as 4 m onths following the last application of the herbicide (Pastorelli 
1998).  This suggests that metabolites of DCPA can remain in the body for an extended 
period of time. 
   We r eport her e f or t he f irst t ime t he i mmunotoxic ef fects of  the DCPA 
metabolites, DCA, NOH-DCA and 6OH-DCA on human Jurkat T cell function.  Jurkat T 
cells have been used for over 20 years as a model for human T cell signaling (Abraham 
2004).  Previous research has demonstrated that exposure of DCPA to human Jurkat T 
cells in hibits I L-2 s ecretion i n a concentration and C a-dependent m anner.  Similar to  
DCPA, DCA inhibits IL-2 secretion, NFAT activity and calcium homeostasis, although at 
higher concentrations than that of DCPA (Fig 3B, 4B , 5B).  Thi s i s in agreement w ith 
others who have reported that immune parameters, including T cell dependent antibody 
production, m yleotoxic ef fects, and I L-6 r esponse in m ouse T cells, were al tered by  
DCPA but  r equired hi gher c oncentrations of  D CA t o pr oduce s imilar ef fects (Barnett, 
Gandy et al. 1992; Malerba, Castoldi et al. 2002)(Zhao unpubl data).   
NOH-DCA appears more cytotoxic to T cells than both DCPA or DCA and inhibits 
IL-2 secretion more potently, with a 90% reduction in IL-2 at 50µM NOH-DCA whereas 
at 50µM DCPA I L-2 is decreased by only 50% (Fig 2A, 2C, 3A, 3C).  H owever, a 2. 5 
fold dec rease i n N FAT ac tivity i n c ells e xposed t o 50µM D CPA r esulted i n a 50% 




in N FAT activity ( Fig. 4A  a nd 4C ).  Th e ef fect of  t hese m etabolites on c alcium 
homeostasis suggests that the mechanism by which NOH-DCA inhibits IL-2 secretion is 
different f rom that of  DCPA (Fig 5A  and 5C ).  N OH-DCA and 6OH-DCA appear ed to 
inhibit IL-2 in a C a-independent manner, whereas the ef fects of  DCPA and DCA on T 
cell function are elicited in a Ca-dependent manner.  Ther e is no data available on t he 
immunotoxic effects of 6OH-DCA, however, McMillan et al reported that although 6OH-
DCA produced metHb adducts NOH-DCA was 10 times more potent (McMillan, Leakey 
et al . 199 0).  O ur dat a s upports a  diminished ef fect of 6O H-DCA on  T c ell f unction.  
6OH-DCA and NO H-DCA ar e equally c ytotoxic but 6O H-DCA only dec reased IL-2 
secretion at 50µM compared to 5µM NOH-DCA (Fig 2C and 2D).  Calcium homeostasis 
is also unaffected by treatment with 6OH-DCA.  The mechanism for the decreased in IL-
2 and NFAT activity in 6OH-DCA and NOH-DCA exposed cells is unknown.  
Approximately 45% of all herbicides contain a c arbon-chlorine bond and 1/6th of 
all organochlorines r equires s pecial s afety pr ecautions f or u se i n t he w orkplace 
(Naumann 2000).  In many cases the biological activity of the compound is conferred by 
the presence of  the chlorines (Naumann 2000).  The best known example is DDT, as 
the removal of  two specific c hlorines r enders t his p esticide in active (Crinnion 20 09).  
Other toxic organochlorine pesticides include atrazine and 2,4-D.  In order to determine 
the r ole t hat c hlorine s ubstituents hav e i n D CPA-exposed T cells, w e substituted 
fluorines for both of  the chlorines found in DCPA and  DCA.  I n the last 20 y ears, the 
number of  f luorinated c hemicals has  i ncreased s ignificantly a nd now  2 8% of  al l 
halogentated agrochemicals are f luorinated (Jeschke 2004).  The pos ition and number 




Unlike DCPA and DCA, DFPA and DFA are not cytotoxic (up to 400µM) and do not alter 
IL-2 s ecretion, N FAT ac tivity or  c alcium h omeostasis ( Fig. 6) .  Thi s i ndicates t hat 
chlorine substitution plays an important role in exerting immunotoxic effects in T cells.  It 
has been reported t hat 3,4-DFA is toxic t o t he l iver but at  concentrations higher t han 
that f or 3, 4-DCA, s uggesting a negat ive biological r ole f or c hlorine at  t he 3 an d 4  
positions (Hong, A nestis et  al . 2000).  S everal pos sibilities e xist f or t he di fferential 
effects observed w ith chlorine an d f luorine.  Fi rst, f luorines are h ighly electronegative 
and act only as hydrogen acceptors whereas chlorine and ot her halogens act as both 
hydrogen acceptors and donors.  Second, trifluoro-substitution can increase lipophilicity 
but mono- or difluoro-substitution has been reported to decrease it (Purser, Moore et al. 
2008).  It has recently been reported that, in Jurkat T cells, DCPA becomes localized to 
the c ytosol, i ndicating t hat i n c an pas s t hrough t he membrane (Hanson, Peer et  a l. 
2010).  I ncreases in electronegativity and l ipophilicity could prevent binding to proteins 
targeted by  D CPA.  Las tly, f luorines ar e s imilar i n s ize t o h ydrogen a nd m ay n ot 
produce t he c onfirmation r equired t o e licit t he ef fects of  D CPA.  T hese s pecific 
properties of f luorine may be r esponsible for the apparent reversal of effects observed 
in DFPA and DFA treated cells. 
In conclusion, metabolites of DCPA display differential effects on Jurkat T cells.  
Although DCA e licits s imilar Ca-dependent ef fects on I L-2 secretion, t he par ent 
compound, DCPA, is more toxic.  H owever, DCPA is quickly metabolized to DCA and 
persists in the body possibly allowing DCA to accumulate to concentrations greater than 
that of DCPA. Hydroxylation of DCA can result in the production of NOH-DCA and 6OH-




independent m anner at  l ow c oncentration ( 5µM N OH-DCA).  Fur ther s tudies a re 
required to determine the mechanism for the decreases in IL-2 observed in NOH-DCA-
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Calcium (Ca) is a ub iquitous second messenger that is required in almost all cells and 
at al most all s tages of  l ife.  This w idespread us e of  C a i n i ntracellular s ignaling 
pathways requires t ight r egulation.  C alcium r elease-activated c alcium ( CRAC) 
channels a re a t ype of  s tore-operated ( SOC) c hannel t hat hav e been i dentified and  
described i n det ail, es pecially i n i mmune c ells. A ctivation of  C RAC c hannels results 
from the depletion of Ca located in endoplasmic reticulum (ER) stores.  Depletion of the 
ER stores signals the ER protein, Stim1 to aggregate into punctate structures near the 
plasma m embrane w here i t clusters w ith t he pl asma m embrane pr otein, O rai1. 
Formation of the Stim1/Orai1 complex activates CRAC channels allowing the selective 
entry of Ca into the cell.  A lterations in the activation and assembly of Stim1 and Orai1 
have serious consequences on human health. DCPA is a post-emergent herbicide used 
in rice fields and numerous studies suggest that it has negative effects on t he immune 
system.  We have previously reported that DCPA inhibits Ca influx in Jurkat T cells with 
adverse effects on I L-2 production and NFAT activity.  H ere we examine the effects of 
DCPA on  S tim1 pu ncta f ormation.  U pon E R C a s tore de pletion, HEK293 c ells 
expressing Y FP-Stim1 f ormed p uncta-rich regions near t he pl asma m embrane of  t he 
cell.  DC PA-treated cells formed few punctate structures and f ailed to form the puncta-
rich regions when ER stores were depleted. Here we propose a mechanism and identify 







Calcium (Ca) is a ubiquitous second messenger that is important in all aspects of 
life, from conception to death.  Many signaling systems are used to regulate the flow of 
Ca into and out of a cell.  Store-operated Ca entry (SOCE) is used by virtually all animal 
cells to increase intracellular Ca levels in response to a stimulus (Feske 2009).  As the 
name implies, entry of Ca into the cell is regulated by the levels of free Ca stored in the 
lumen of the ER.  SO CE is initiated by stimulation of receptors on the surface of a cell 
which leads to the production of IP3.  IP3 binds to the IP3 receptor on the surface of the 
ER resulting in the release of Ca from the ER stores.  Stim1, an ER protein with an EF-
hand domain extending into the lumen of the ER, acts as a Ca sensor to detect changes 
in Ca.  Multimerization of Stim1 initiates interactions with Orai1 proteins, located in the 
plasma m embrane, and r esults i n t he activation o f C RAC c hannels (Fig 2) . The 
formation of Stim1-Orai1 c lusters is essential for CRAC activation and translocation of 
Stim1 t o a reas w ithin 10 -25nm of t he m embrane oc curs w ithin 6 -10 s econds pr ior t o 
CRAC activation (Wu, Buchanan et al. 2006). Opening of CRAC channels enables the 
refilling of  ER C a s tores and f unctions t o produce t he s ustained and e levated Ca 
signaling required for activation of various s ignaling pathways.  I n T c ells, influx of Ca 
through C RAC c hannels and t he s ubsequent a ctivation o f t he C a-dependent 
transcription f actor N FAT ar e critical f or t he e xpression of  I L-2, an i mportant ear ly 
cytokine r esponsible f or ac tivation, pr oliferation and di fferentiation of  s everal i mmune 





Stromal Interaction Molecule-1 (Stim1) 
Stim1 is a single transmembrane protein that has been identified as an essential 
protein in SOC signaling in many cells types.  Originally described in 1996 this protein, 
then des ignated S IM, w as i dentified i n a s creening f or pr oteins t hat bind B c ell 
precursors (Oritani and K incade 1996).  The gene f or this protein was cloned from the 
human chromosome region 11p15.5 and is evolutionarily conserved from Drosophilia to 
mammals.  Further studies revealed that Stim1 had t umor suppressor abilities in some 
cancer c ell l ines (Sabbioni, B arbanti-Brodano et  al . 1997; S abbioni, V eronese et  al . 
1999) .  The link between SOCE and Stim1 came in 2005 when Roos et al discovered 
that, in  siRNA against Stim, in Drosophila, decreased Ca influx (Roos, DiGregorio et al. 
2005). Sim ultaneously, Liou et  al  screened 2304 hum an genes  using s iRNA for each 
gene and looked for those altering Ca influx in HeLa cells (Liou, Kim et al. 2005).  They 
identified 2  genes , Stim1 and Stim2. S tim1 and Stim2 ar e ub iquitously expressed i n 
almost all mammalian tissue and, to date, the role of Stim1 in SOCE has been identified 
in num erous c ell t ypes i ncluding T c ells, B  c ells, m acrophages, m ast c ells, pl atelets, 
skeletal m uscle, s mooth m uscle, v ascular endothelium and ne uronal c ells (Soboloff, 
Spassova et al. 2006; Frischauf, Schindl et al. 2008).  
Stim1 i s c haracterized as  a 68 5 am ino a cid, 90k Da, Ty pe I  t ransmembrane 
domain pr otein (Williams, M anji et  al . 2 001) (Fig 1) .  The  N  t erminus r esides in t he 
lumen of  t he E R an d t he C -terminus i n t he c ytosol. The N  t erminus i s a hi ghly 
conserved r egion t hat c ontains a s ingle s terile al pha motif (S AM) d omain th at i s 
modified by N-linked glycosylation at 2 sites (Asn131 and Asn171).  The SAM domain is 




domain r esults i n t he f ailure of  S tim1 to f orm punc ta and C RAC c hannels ar e not  
activated (Baba, Hayashi et al. 2006). In addition, the presence of an EF-hand domain, 
in the N terminus acts as a Ca sensor for ER Ca stores.  A single mutation (Asp76Ala) 
in the EF-hand domain of Stim1 results in prelocalized puncta formation in the absence 
of ER Ca store depletion along with constitutive activation of the CRAC current (ICRAC) 
(Liou, Kim et al. 2005; Zhang, Yu et al. 2005). 
The C -terminus of  S tim1 i s l ocated i n t he c ytosol and c ontains 2 hi ghly 
conserved alpha helical coiled-coil regions, an er zin-radixin-moesin (ERM) domain and 
Ser and  L ys-rich r egions (Stathopulos, L i et al . 200 6).  W ithin t he E RM dom ain, a 
Stim/Orai-activating r egion ( SOAR) and a Stim1 hom omerization dom ain ( SHD) hav e 
recently been identified (Muik, Fahrner et al. 2009; Yuan, Zeng et al. 2009).  Deletion of 
the E RM dom ain d isrupts S tim1 punc ta f ormation and C RAC ac tivation.  Fur ther 
mutational studies have i dentified a C RAC-activating domain (CAD), al so called Orai-
activating small fragment (OASF), within the SOAR domain (Muik, Fahrner et al. 2009; 
Park, Hoover et al. 2009).  E xpression of CAD alone is sufficient to activate Orai1 and 
deletion of  CAD r esults i n d iffuse S tim1 expression when ER Ca s tores ar e dep leted 
(Park, Hoover et al. 2009). Stim1 also contains a CRAC modulatory domain (CMD), C 
terminal to the SHD, which i s reported to regulate the degree of  coupling to Orai1 as  
well as CRAC activation (Derler, Fahrner et al. 2009).  The extreme C terminus of Stim1 
contains a polybasic region which can bind calmodulin, in a calcium-dependent manner, 





Figure 1. Domain structures in human Stim1 and Stim2 
 
It is estimated that 20-30% of Stim1 is expressed on t he plasma membrane but 
limited and conflicting data is available to determine to its function (Manji, Parker et al. 
2000). Some s tudies hav e i dentified a r ole f or pl asma m embrane bou nd Stim1 i n 
platelet ag gregation and vascular smooth m uscle cell m igration ( Jardin, L opez et  al . 
2009) (Li, Sukumar et al. 2008). In addition, a Stim1 antibody, applied externally, blocks 
ICRAC in Jurkat T c ells and SOCE in HEK293 cells, revealing that Stim1 on the plasma 
membrane m ay be f unctionally i mportant (Soboloff, S passova et al . 2006 ; S passova, 
Soboloff et al. 2006).  However, Liou et al reported did not detect Stim1 on the plasma 
membrane of HeLa cells, indicating the role of Stim1 on the plasma membrane may be 
cell type specific (Liou, Fivaz et al. 2007).   
Knockdown and mutational studies of Stim1 
Numerous knockdown and mutational s tudies hav e c ontributed t o t he 
understanding of Stim1 in SOCE.  Knockdown of Stim1 in several cell types, as well as 




2008; Picard, McCarl et al. 2009).  Overexpression of Stim1 and Orai1, in HEK293 and 
Jurkat T cells, greatly increased ICRAC with a 10-60 fold increase in Ca influx but with no 
change in basal resting Ca levels (Soboloff, Spassova et al. 2006; Soboloff, Spassova 
et al . 200 6).  H owever, ov erexpression of O rai1 a lone does not alter ICRAC, but 
overexpression of Stim1 increased ICRAC 2 fold, indicating an important role for Stim1 in 
CRAC activation (Vig, Peinelt et al. 2006).   
Stim1-/- mice di e in utero or s hortly a fter bi rth but s tudies i n mice wit h 
conditionally targeted deletion of Stim1 have been reported (Oh-Hora, Yamashita et al. 
2008).  Conditional deletion of Stim1 in T cells and f ibroblasts showed almost no C a2+ 
influx in r esponse t o dep letion of  ER Ca2+ stores.  In ad dition, T CR-stimulated 
production of IL-2, IFN-γ, and I L-4 production is s ignificantly decreased in T cells from 
Stim1-/- mice (Oh-Hora, Yamashita et al. 2008).  
Recently, three i ndividuals f rom a s ingle f amily w ere i dentified w ith a  
homozygous nonsense mutation in Stim1.  These individuals have no mutations in Orai 
but hav e dec reased S OCE and pr ofound i mmunodeficiencies. Ex vivo studies 
demonstrated that SOCE could be partially rescued by introducing functional Stim1 but 
only partially rescued with Stim2 (Picard, McCarl et al. 2009).  
Stim2 
Stim2 was originally identified by Williams et al during a screening for Stim1-like 
sequences (Williams, Manji et  a l. 2001) . D ifferential levels of  phosphorylation account 
for t wo m olecular m ass i soforms ( 105kDa and  1 15kDa).  Stim2 is ubiquitously 
expressed and al though Stim1 and S tim2 hav e hi gh s equence hom ology, t here ar e 




(Williams, Manji et  al . 2001).  The N-termini of  both proteins are almost identical, with 
the noted except that Stim1 has 2 N -linked glycosylation sites in the SAM domain and 
Stim2 onl y has  o ne site.  The greatest di fferences l ie w ithin t he c ytosolic C -terminal 
domain.  As m entioned pr eviously, S tim1 i s e xpressed i n t he E R and t he pl asma 
membrane, however, an E R retention sequence in the C-terminus of Stim2, but not on 
Stim1, confines its expression to the ER (Wang, Deng et al. 2009).  I n addition, the C-
terminus of  S tim2 c ontains ph osphorylated S er/His r esidues and a large P ro-rich 
domain. 
In vitro and in vivo experiments have demonstrated that Stim2 can o ligomerize 
with St im1, in dicating a pos sible f unctional i nteraction bet ween S tim1 and S tim2 
(Stathopulos, Zheng et al . 2009;  W ang, D eng et  a l. 2 009). O verexpression of  Stim2 
does not result in puncta formation when ER stores are depleted but puncta formation 
does occur when both Stim1 and Stim2 are overexpressed (Soboloff, Spassova et  a l. 
2006).  In HEK  293 and Jurkat T cells, overexpression of  S tim2 alone decreased Ca 
influx and I CRAC but knockdown o f Stim2, us ing siRNA, has l ittle ef fect on Ca influx or  
ICRAC (Dziadek and  J ohnstone 2 007). I nterestingly, o verexpression of  bot h S tim2 and  
Orai1 slightly increase baseline ICRAC when ER stores were filled and addition of 50µM 
2-APB, normally inhibitory, increased I CRAC when Stim2 and O rai1 are overexpressed. 
(Parvez, Beck et  al . 2008)   This data suggests that Stim2 acts as a r egulator of  SOC 
signaling.  Fur ther s tudies r evealed t hat expression of  t he m utant S tim1(D76A) forms 
puncta w hen E R s tores ar e f ull and pr oduced c onstitutive C a ent ry but  when c o-
expressed with S tim2,  puncta f ormation and constitutive C a ent ry could be  r eversed 




mediated SOC at a point downstream of puncta formation.  I t has been proposed that 
the effects of Stim2 are dependent on its ratio with Stim1 and that after store depletion, 
Stim1 and Stim2 aggregate and organize into puncta (Soboloff, Spassova et al. 2006).  
If the Stim1-Stim2 ratio is high, functional coupling to Orai1 occurs and SOCE proceeds 
but if the ratio is low, Stim2 interferes with coupling and inhibits SOCE. 
There ar e also s ome studies t hat s uggest t hat S tim2 is involved in  s tabilizing 
basal cytosolic and ER Ca levels (Brandman, Liou et al. 2007).  Knockdown of Stim2 in 
HEK293 c ells r educed basal cytosolic a nd E R C a l evels w hereas ov erexpression 
increased basal C a levels. S imilar s tudies hav e r eported t hat Stim2 responds t o 
changes i n E R C a ne ar r esting l evels, w hereas S tim1 i s activated on ly w hen E R C a 
stores are depleted (Frischauf, Schindl et al. 2008).  
Orai / CRACM 
In 2006,  F eske et  a l i dentified a pr otein in pat ients with a  her editary f orm of  
severe combined immunodeficiency (SCID) syndrome whose T cells f ailed to ac tivate 
CRAC c hannels (Feske 2009) .  They  nam ed t his pr otein O rai1, after the Greek 
mythological Orai, keepers of heaven’s gate.  At the same t ime Vig et al identified the 
same pr otein t hrough a s iRNA s creening of  t he D rosophilia g enome f or proteins t hat 
altered Ca influx and designated the protein CRACM1 (Vig, Peinelt et al. 2006). Orai1 or 
CRACM1 i s di stributed di ffusely in t he pl asma m embrane at  r est but  aggr egates an d 
interacts w ith S tim1 i n ov erlapping c lusters af ter s tore depl etion t o ac tivate C RAC 
channels (Fig 2)  (Vig, Beck et  a l. 2006;  Navarro-Borelly, Somasundaram et  al. 2008).  
Förster resonance energy transfer (FRET) analysis confirmed that Stim1 and Orai1 co-




(Navarro-Borelly, Somasundaram et  al . 2008). The c oupling of  Stim1/Orai1 to activate 
CRAC c hannels is d ynamic bu t f ully r eversible when E R s tores ar e r eplenished 
(Mignen, Thompson et al. 2008).  
The O rai f amily c onsists of  3 m embers, Orai1, O rai2 and O rai3. A f unctional 
CRAC channel requires the formation of an Orai tetramer.  The ex act contribution from 
each family member has not been fully elucidated but appears to be dependent on cell 
type (Mignen, Thompson et al. 2008).  Orai1/CRACM1 is the dominant form expressed 
in most mammalian cells. It is a 33kDa, 301 amino acid protein with 4 t ransmembrane 
(TM) spanning d omains w ith bot h N  and C t ermini located i n t he c ytosol.  O rai1 has 
been s hown t o f orm t he es sential por e-forming un it of  t he C RAC c hannel (Prakriya, 
Feske et al. 2006; Feske 2010). The N terminus of Orai1 contains a Pro/Arg-rich region 
(not f ound in O rai2 or  O rai3) w ith a c onserved pol ybasic ( Arg/Lys) m otif be fore TM 1.  
The P ro/Arg-rich r egion i s t hought t o pl ay a r ole i n Orai1 as sembly.  The C -terminus 
region contains a c oiled-coil domain and protein i nteraction domains.  D eletion of  t he 
complete N  t erminus i n O rai1 abol ishes Ca i nflux but c o-clustering i nteraction w ith 
Stim1 i s r etained, i ndicating t hat t he C -terminus c ontains r egions i mportant i n t he 





Figure 2. Schematic of Stim1-mediated Orai1 activation of CRAC channels 
 
The t ransmembrane (TM) regions ar e i mportant i n f orming t he C RAC c hannel 
pore. Based on m utational analysis, TM1 and TM3 and t he extracellular loop between 
TM1 and T M2 form the CRAC channel pore (Vig, Beck et al. 2006; Yeromin, Zhang et  
al. 200 6).  A G lu106Asp m utation i n TM 1 and  a G lu190Gln mutation i n TM 3 b oth 
decrease the Ca selectivity of  the pore through a pr oposed mechanism that increases 




2007). As p to A la mutations i n am ino acids 11 0, 112,  and  114 i n t he TM 1-TM2 
extracellular loop also alters ion selectivity (Yeromin, Zhang et al. 2006).   
Interaction with Stim1 is thought to be mediated through an amphipathic domain 
on the C terminus of Orai1 and also through two hydrophobic Lys residues.  Isolation of 
a 107 am ino acid region, within the coiled-coil domain of the C-terminus of Stim1, can 
co-immunoprecipitate with O rai1 and ac tivate CRAC c hannels i ndependent of  t he ER 
Ca stores (Wang, Deng et al. 2009). 
In HEK 293 and Jurkat T cells, overexpression of both Stim1 and Orai1 produce 
an e xtremely l arge I CRAC but o verexpression of  O rai1 al one pr oduces n o i ncrease i n 
ICRAC (Mercer, D ehaven et  al . 20 06; S oboloff, S passova et  al . 20 06; V ig, B eck et  al . 
2006).  Knockdown o f O rai1 abol ishes C a i nflux and  C RAC activity (Vig, B eck et  al . 
2006).  Expression of Orai1 and Stim2 increased cell proliferation of HEK 293 cells and 
endothelial c ells, w ith no ev ident r ole f or S tim1 ( Potier, G onzalez et  al . 2009;  E l 
Boustany, Katsogiannou et  al . 2 010). S ilencing O rai1 or  S tim2 abol ished proliferation 
but silencing Stim1 had no effect. 
Orai2/CRACM2 and Orai3/CRACM3 
Orai1 is the dominant form of  Orai expressed in most cells lines, however, Orai2 and 
Orai3 can also produce ICRAC upon co-expression with Stim1 (Lis, Peinelt et  al . 2007).  
In HEK 293 cells, overexpression of both Stim1 and Orai2 increased Ca influx and ICRAC 
but t o a l esser degr ee t han i n c ells ov erexpressing both S tim1 and O rai1(Soboloff, 
Spassova et al . 2006 ).  I n addi tion, overexpression of  bot h S tim1 and O rai2 has  n o 
effect i n T c ells f rom S CID pat ients (Feske 20 10) When S tim1 an d O rai3 a re 




of O rai2 w ith t he O rai1 C -terminus i ncreases I CRAC, a nd de letion of  par t of  N -term o f 
Orai1 results in a diminished Ca influx, comparable to that of wild type Orai2 and Orai3 
(Li, Lu et al. 2007; Yuan, Zeng et al. 2009).  In addition, four Orai1 proteins are thought 
to hom odimerize t o f orm an ac tive C RAC channel but , bas ed on c o-
immunoprecipitaions experiments, heteromultimerization can also occur between Orai2 
and Orai3 (Penna, Demuro et al. 2008; Maruyama, Ogura et al. 2009).  Th ese studies 





MATERIALS AND METHODS 
Cell lines  
Experiments w ere per formed us ing human em bryonic k idney-293 (HEK-293) c ells (a 
generous gift from J. Soboloff).  HEK 293 cells were maintained in Dulbecco's modified 
Eagle's medium (DMEM) (Mediatech, Herndon, VA) supplemented with 10% (v/v) heat-
inactivated fetal bov ine s erum (FBS) ( Hyclone, Lo gan, U T), 1 00 un its/ml pen icillin 
(BioWhittaker, W alkersville, M D), 100 µg/ml s treptomycin (B io W hittaker), 2 .0 m M 
glutamine (BioWhittaker).  The cultures were kept at 37°C in 5% CO2. 
Reagents 
Stock solutions of  DCPA (ChemServices, West Chester, PA) were di luted in absolute 
ethanol ( AAPER A lcohol a nd Chemical Company, S helbyville, KY).  V ehicle s amples 
were treated with an equivalent concentration (0.1%v/v) of ethanol.   
Transfections 
The day  pr ior t o t ransfection, 0.7 x  10 5 HEK 293 cells were added to Delta T c ulture 
dishes ( Bioptechs, Butler, P A) i n D MEM s upplemented w ith 10%  F BS, w ithout 
antibiotics and i ncubated overnight at  37 °C in  5% CO 2. The day  of  t ransfection, HEK 
293 c ells were t ransfected us ing Li pofectamine 20 00 ( Invitrogen, C arlsbad, C A) a s 
recommended by  the manufacturer.  B riefly, for each plate 1µl  of L ipofectamine 2000  
was pl aced i n 5 0µl of O ptiMem ( Invitrogen) and i ncubated at  r oom t emperature f or 5  
minutes.  The t ransfection solution was added to a t ube with 50µl OptiMem and 0.5µg 
YFP-Stim1 plasmid (a gener ous gi ft f rom J . S oboloff) and  i ncubated at  r oom 
temperature for 20 minutes.  The DNA-transfection complex was added to the HEK 293 




with fresh, complete DMEM and incubate for 24 hours at 37°C in 5% CO2. On the day of 
the experiment the cells were placed in buffer containing 140 m M NaCl, 5 m M KCl, 1 
mM MgCl2, 10 m M glucose, 15 m M Hepes, 0.1% BSA and 2 m M CaCl2.  Ce lls we re 
kept at  37°C throughout the experiment and r eagents added t o the plate as indicated.  
YFP- Stim1 images were acquired using a 60x/1.49 Apo TIRF objective and 1x1 binning 
on a N ikon E clipse TE2000-E i nverted f luorescent m icroscope equ ipped w ith t he 
Perfect Focus system and a Photometrics CoolSNAP HQ CCD camera.  A  z -stack of  
fluorescent images was collected at  1  µm intervals every 20 s econds for 10 m inutes.  
Cells w ere m aintained at  37 °C with a B ioptechs D elta T di sh heater.  I mages w ere 
acquired and analyzed us ing t he N IS-Elements software package. Images shown are 







In T c ells exposure to DCPA leads to decreased IL-2 production, NFAT activity 
and calcium influx.  Since Ca influx in T cells is regulated by CRAC channels we sought 
to determine the ef fects of  DCPA on Stim1 puncta formation.  C haracterization of  the 
role of S tim1 i n C RAC c hannel ac tivation has  bee n t horoughly i nvestigated i n bo th 
Jurkat and HEK 293 cells (Parekh 2006; Feske 2007; Prakriya 2009).  In both cell types, 
Stim1 puncta formation, i ts interaction with Orai1 and ac tivation of  CRAC channels al l 
occur in a similar manner.  HEK 293 cells are adherent, easy to transfect cells that have 
a relatively large cytoplasmic space that al lows easy identification of puncta formation.  
These c ells w ere us ed t o det ermine t he e ffects of  D CPA on S tim1 punc ta f ormation.  
HEK 293 cells were t ransfected w ith a YFP-Stim1 plasmid and E R Ca stores w ere 
depleted with 2µM thapsigargin approximately 70-80 s after data collection began (Fig 
3A).  Cells treated with DCPA received 100µM DCPA just pr ior to the addition of 2µM 
thapsigargin (Tg).  Images were collected over a 16  minute period.  P rior to treatment, 
all cells displayed a d iffuse distribution of YFP-Stim1.  Upon depletion of ER Ca stores 
with Tg in control cells, puncta formation was observed after approximately 7.5 minutes 
and continued t o f orm ov er time ( white arrows i ndicate ar eas of  punc ta f ormation).  
Puncta-rich r egions ar e appar ent ar ound t he m embranes of  t he cells. Upon ER s tore 
depletion, cells t reated w ith DCPA appeared to form some punc ta but fail t o form the 
puncta-rich regions observed in control cells (Fig.3B).  These results suggest that DCPA 








Figure 3A Formation of Stim1 puncta-rich regions in control cells 
HEK 293 cells were t ransfected w ith Y FP-Stim1 and s tore-operated C a i nflux w as 
initiated by depletion of ER Ca stores with 2µM Tg.  Tg was added to control cells at=70 









Figure 3B DCPA inhibits formation of Stim1 puncta-rich regions 
HEK 293 cells were t ransfected w ith Y FP-Stim1 and s tore-operated C a i nflux w as 
initiated by depletion of ER Ca stores with 2µM Tg.  100µM DCPA was added prior to 






Regulation of  i ntracellular c alcium l evels i n c ells i s es sential f or al most al l 
aspects of  c ell f unction, and al terations i n c alcium hom eostasis c an hav e pr ofound 
effects on cell function and v iability.  Many cells, including HEK 293 and Jurkat T cells, 
use SOC channels to regulate Ca influx (Peinelt, Vig et al. 2006; Vig and Kinet 2009).  
SOCE is a form of Ca influx that is dependent on t he depletion of i ts ER Ca stores in 
order to activate Ca channels on the plasma membrane.  CRAC channels are the most 
widely known and d escribed SOC channel and were identified over 20 y ears ago (Vig 
and K inet 2007; P rakriya 2009;  Vig a nd K inet 2009) .  Un til r ecently, CRA C c hannels 
could only be characterized by electrophysiological methods.  The mechanism by which 
CRAC c hannels f unction has  b ecome c learer w ith t he i dentification of  2 es sential 
proteins, Stim1 and Orai1. Stim1 is a single transmembrane protein that predominantly 
resides in the ER, with some studies indicating a role for Stim1 in the plasma membrane 
(Baba and Kurosaki 2009).  I t contains an EF-hand domain that acts as a Ca sensor in 
the lumen of the ER.  In unstimulated cells, both Stim1 and Orai1 proteins are diffusely 
distributed i n t he E R and pl asma m embrane, r espectively ( Liou, K im et al . 2005) .  
Depletion of E R C a s tores r eleases C a f rom t he S tim1 E F-hand and  i nduces a 
conformational change that facilitates aggregation of Stim1 and results in the formation 
of overlapping clusters with Orai1, in areas close to the plasma membrane (Luik, Wang 
et al. 2008).  This Stim1/Orai1 complex activates CRAC channels and allows Ca to flow 
into the cell (Fahrner, Muik et al. 2009).  Once inside the cell, Ca plays an important in 




Alterations in Stim1 can have profound effects on cell function and ,in T cells, can 
result i n severe immunodeficiencies (Feske 2009) .  Recently three individuals, from a  
single family, were identified with a h omozygous nonsense mutation in Stim1 but  with 
no m utations i n O rai1 (Picard, McCarl et  al. 200 9).  Thes e pa tients hav e pr ofound 
immunodeficiencies and l imited T cell SOCE.  I n addition, several other in vitro and in 
vivo studies support the important role for Stim1 in SOCE and calcium signaling (Feske, 
Prakriya et al. 2005; Feske 2010).  Knockdown of Stim1 in several cell types, including 
Hek 293 and J urkat T c ells, r esulted in i nhibition of I CRAC whereas ov erexpression of  
Stim1 i ncreased I CRAC 2 f old (Liou, K im et  al . 2005) .  In vivo experiments, w ith a 
conditional knockdown of  S tim1 i n m ice, r evealed a lmost no C a i nflux i n response t o 
depletion of Ca stores (Oh-Hora, Yamashita et al. 2008).  TCR-stimulated CD4+ T cells 
from these mice also produce significantly less IL-2, IFN-γ, and IL-4.  
Inhibitors o f SOCE have been described but most have proven non-specific for 
CRAC channels (DeHaven, Smyth et al. 2008; Nam, Shin et al. 2009; Salido, Sage et 
al. 2009).  A widely used modulator of CRAC channels is 2-APB (Bootman, Collins et al. 
2002).  It is a bimodal modulator that activates CRAC at low concentrations (<5µM) and 
inhibits C RAC at  hi gher c oncentrations ( >10µM) ( DeHaven, S myth et  al . 2 008).  W e 
have previously reported that DCPA inhibits Ca influx in Jurkat T cells and at tenuates 
the enhanced Ca influx observed with low concentrations of 2-APB (Lewis, Brundage et 
al. 2008).  Here we more clearly define the mechanism by which DCPA alters Ca influx. 
HEK 293  cells have a d iffuse ex pression of  Y FP-Stim1 w hen cells are a t r est and  
aggregate into punctate structures when ER Ca stores are depleted.  DCPA decreased 




form in DCPA-treated cells but the dense puncta-rich regions observed in control cells 
were never observed.  We conclude that DCPA inhibits Stim1 puncta formation in HEK 
293 cells and extend the results here to conclude that DCPA also inhibits Stim1 puncta 
formation in Jurkat T cells.  Both cells lines are known to express CRAC channels and 
overexpression and m utational studies in both cells l ines respond in a s imilar manner. 
Our data, in Jurkat T cells, supports a mechanism whereby inhibition of Stim1 results in 
decreased Ca i nflux, NFAT ac tivity and I L-2 pr oduction.  I n addi tion, CRAC channels 
are the only Ca channels expressed on T c ells that respond to ER store depletion.  A  
recent study examining the localization of DPCA in Jurkat T c ells concluded that, after 
stimulation, DCP A is lo calized to t he c ytosol a nd not f ound in t he m embrane or  
subcelllular f ractions ( Hanson, Peer et  al . 2010) .  Thi s dat a s upports a r ole f or a  
mechanism in which DCPA interact with Stim1 in the cytosol to inhibit puncta formation. 
An anal og of  2 -APB w as r ecently i dentified as  a pot ential i nhibitor of  S tim1 but  t he 
specificity of i ts ac tions ar e unk nown ( Goto, S uzuki et  al . 2010) .  N o ot her k nown 
inhibitors of Stim1 have been reported.  DCPA may serve as a novel inhibitor of Stim1 
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 CHAPTER 5 
 
GENERAL DISCUSSION 
The overall goal of this dissertation was to determine the effects that DCPA and 
its m etabolites hav e on T c ell ac tivation and f unction and t o pr opose a pos sible 
mechanism t o ex plain t he ef fects. N umerous s tudies hav e bee n c onducted on t he 
immunotoxic ef fects o f DC PA ( reviewed i n (Salazar, U styugova e t al . 2008) .  Ea rlier 
studies in mouse models and human cell lines, laid the foundation for a more detailed 
investigation into the effects of DCPA on T cells.  In addition, it is known that DCPA is 
metabolized quickly in the liver of mammals, but little immunotoxic data is available on 
the ef fects of  i ts m etabolites ( McMillan, Fr eeman et  al . 1990) .  The f irst goal  w as t o 
determine t he ef fects of  D CPA and i ts m etabolites on hum an T c ell f unction and 
activation by e xamining i mmune par ameters and s ignaling ev ents. O nce t his w as 
determined, a possible mechanism for these effects was then investigated.  The results 
of these experiments shed l ight on t he importance of investigating metabolic products 
when evaluating the immunotoxicity of chemicals and reveal that the effects of DCPA 
on T cells may provide a novel mechanism for immunosuppression. 
In T cells, IL-2 is one of the first cytokines to be expressed and its transcription is 
dependent on the cooperative DNA binding of AP-1, NFAT and NF-κB (Jain, Loh et al. 
1995; S erfling, B erberich-Siebelt et  al . 2007) .  N FAT i s a t ranscription f actor t hat i s 
strictly ca lcium-dependent. I n T c ells, ac tivation of  N FAT oc curs t hrough a s eries of  
complex signaling events that begin with the recognition of a foreign peptide, and c o-
stimulation of  t he C D28 r eceptor.  ITAMs, l ocated on t he i ntracellular por tion of  t he 




and ada pter pr oteins t hat f orm t he i mmunological s ynapse.  O ne i mportant 
consequence of this is the recruitment of PLC-γ which hydrolyzes the membrane l ipid 
PIP2 r esulting i n t he pr oduction of  I P3 and D AG.  D AG r emains i n t he membrane 
where is plays a role in the activation of Ras and PKCθ pathways.  IP3 is released into 
the c ytosol and bi nds t o t he I P3-R o n t he ER a llowing t he release of  C a f rom t he 
internal E R C a s tores.  D epletion of  t he E R s tores r eleases C a f rom the E F-hand 
domain on  S tim1 al lowing ag gregation of  S tim1 and i nteraction w ith O rai1 near  t he 
plasma m embrane ( Luik, Wang et  al . 2008 ).  C lustering of  S tim1 and O rai1 ac tivate 
CRAC c hannels and allows t he s elective e ntry of  C a i nto t he c ell.  Thi s i ncrease i n 
intracellular Ca enables it to bind to sites on calmodulin (CaM).  The Ca-CaM complex 
binds to t he r egulatory s ubunit of  c alcineurin, thereby ac tivating i ts ph osphatase 
activity. Dephosphorylation of  N FAT, by c alcineurin, e xposes a nuc lear l ocalization 
sequence which leads to translocation of  NFAT into the nuc leus.  NFAT-driven gene 
expression i s h ighly dependent on a sustained and el evated Ca in flux (Rao 200 9).  
Patients w ith T c ells t hat have a ltered CRAC function also d isplay changes in NFAT 
activity and IL-2 production that results in a SCID-like syndrome (Feske, Gwack et al. 
2006).  In  a ddition, IL-2 is  im portant i n T c ell homeostasis and t olerance a nd 
deficiencies c an i mpair T c ell activation, proliferation and lead t o age -dependent 
tolerance and anergy (Smith-Garvin, Koretzky et al. 2009).  
Immunotoxic studies indicate that exposure of DCPA to C57/B6 mice resulted in 
thymic at rophy, dec reased t hymic w eight and al terations i n s everal t hymocyte 
populations (Barnett and Gandy 1989; Blyler, Landreth et al. 1994).  Mice treated with 




splenocytes s timulated w ith c on-A, a T c ell m itogen ( Zhao, S chafer et  al . 1998) .  
Similar decreases in IL-2 production, as well as mRNA levels, were reported in mouse 
(EL-4) and human T (Jurkat) cell lines (Zhao, Schafer et al. 1999; Brundage, Schafer et 
al. 2004) .  A dditional s tudies confirmed that human Jurkat T c ells exposed to DCPA 
altered c-jun protein levels as well as phosphorylation levels (Brundage, Schafer et al. 
2004).  AP-1 is a transcription factor that is important in T cells for the expression of IL-
2 and is comprised o f c -jun and c -fos. Reductions in c-jun resulted in the decreased 
DNA binding ability of AP-1 with downstream decreases in IL-2.  Transcription of IL-2 is 
dependent on t he cooperative binding of 3 t ranscription factors; AP-1, NFAT and N F-
kB (Jain, Loh et al. 1995).  A lterations in the t iming and binding of these transcription 
factors can have adverse effects on T cell function (Jain, Loh et al. 1995; Hogan, Chen 
et al. 2003). 
Although i mmunological s tudies i ndicate t hat D CPA c an al ter T c ell f unction, 
there is sparse data on the immunotoxic effects of its metabolites.  In humans, DCPA is 
metabolized by  hep atic ac ylamidases t o produce D CA w hich can under go f urther 
biotransformation to produce NOH-DCA and 6OH-DCA (McMillan, Leakey et al. 1990).  
Roberts et al examined DCPA self-poisoning patients and r eported that the estimated 
half-life of  DCPA i n t he body  is 3. 2 hour s and t hat D CA was detectable and m ore 
persistent that DCPA (Roberts, Heilmair et al. 2009).  N o data is available on the half 
life of DCA in humans, but in rats, elimination of DCA is reported to occur after 3 days.  
In humans, DCA is detectable in both occupationally and non-occupationally exposed 
individual and DCA-Hb adducts are detectable in agricultural workers four months after 




Barisano e t al . 2006) .  Thi s i ndicates t hat ex posure t o D CPA m ay r esult i n an  
accumulation of  D CA i n t he body  l ong af ter D CPA had been metabolized.  Tox icity 
studies o n D CA ar e l imited b ut t here h ave be en r eports t hat D CA can a lter 
reproductive, endoc rine, and l iver f unctions ( Valentovic, Y ahia et  al . 1997;  B auer, 
Meyer et  a l. 1998;  Zhang and Li n 2009) . Limited immunotoxicity studies indicate that 
DCA m ay be as  t oxic as D CPA, as  m olar equi valent dos es of  D CPA and D CA 
increased spleen weight and s ize and dec reased NK cell function (Barnett, Gandy et  
al. 1992).  In  contrast, myleotoxic effects are observed in mice exposed to DCPA, but 
not when exposed t o DCA (Malerba, C astoldi et  al . 2002).  In vitro studies, using a  
murine T cell line, resulted in decreased IL-6 production when exposed to 50µM DCPA 
but IL-6 w as on ly i nhibited by  D CA at  hi gher c oncentration ( 300µM) (Zhang 
unpublished data).   
NOH-DCA and 6O H-DCA ar e metabolites t hat hav e been  doc umented i n t heir 
ability to form met-Hb adducts (McMillan, McRae et al. 1990).  Both of these oxidative 
metabolites can convert oxy-Hb to met-Hb, a form of Hb that does not bind or transport 
oxygen.  For mation of  m et-Hb c an l ead t o a s erious m edical c ondition known as   
methemoglobinemia. N OH-DCA i s al so a  nephr otoxicant and can i nduce hem olytic 
anemia (McMillan, B radshaw et  al . 1991;  V alentovic, B all et  al . 200 1).  6 OH-DCA is  
also nephrotoxic but does not induce hemolytic anemia.  In addition, no immunotoxicity 
studies on either NOH-DCA or 6OH-DCA have been conducted. 
The immunotoxic ef fects of  D CPA and its m etabolites on T c ells ar e r eported 
here for the first time.  As a test for overall T cell function, IL-2 secretion was measured 




secretion, up to 78%, in a concentration dependent manner.  Exposure of Jurkat T cells 
to DCA also decreased IL-2 secretion in a concentration dependent manner but only at 
higher c oncentrations ( 100µM and 20 0µM).  A  78 % dec rease i n I L-2 pr oduction 
observed with 100µM DCPA required 200µM DCA to achieve the same inhibition.  This 
suggests t hat D CPA i s a m ore pot ent i nhibitor of  I L-2 s ecretion. Metabolic 
transformation can increase the toxicity of a chemical and, in NOH-DCA treated Jurkat 
T cells, IL-2 levels are decreased significantly more than that of DCPA.  Although 50µM 
NOH-DCA decreased IL-2 by 90%, 50µM DCPA only inhibited IL-2 by 50%, indicating 
that metabolism of DCPA produces a metabolite more toxic than its parent. In addition, 
NFAT ac tivity i s al so i nhibited by  D CPA and i ts m etabolites, al though t o v arying 
degrees. I nterestingly, al though a c oncentration of  50µM N OH-DCA in hibited I L-2 
secretion by  90% , N FAT ac tivity i s onl y r educed 2 f old.  I n c ontrast, 50µM  D CPA 
inhibited IL-2 secretion by  almost 50% but  NFAT ac tivity was decreased 2.5 fold.  In 
addition, 100µM  D CPA dec reased I L-2 s ecretion by  78%  w ith a 8 -fold dec rease i n 
NFAT ac tivity.  Thes e dat a s uggests t hat N OH-DCA a nd D CPA m ay inhibit I L-2 
production through different mechanisms.  To support this hypothesis, DCPA and DCA 
were a lso shown to inhibit Ca influx in a  concentration-dependent manner but  aga in, 
DCPA ap pears t o be a m ore pot ent i nhibitor.  H owever, ev en at  t he hi ghest 
concentrations of 6OH-DCA (50µM) and N OH-DCA (50µM) Ca influx was not altered.  
The mechanism by which NOH-DCA and 6OH-DCA inhibit IL-2 production is currently 
unknown, how ever, m easurements of  N FAT ac tivity and I L-2 s ecretion r equire 
incubations t imes of  5hrs and 24hrs, r espectively, and c alcium f lux w as m easured 




homeostasis at later time points and that may account for the decreases in NFAT and 
IL-2.  It is also possible that NOH-DCA and 6OH-DCA al ter T c ell function through a 
different mechanism that DCPA and DCA.  Fur ther s tudies are required to determine 
the mechanism for these differential effects. 
Several mechanisms could account for the Ca-dependent changes observed in 
Jurkat T c ells exposed t o D CPA and  D CA.  T c ells e xpress 2  pl asma m embrane 
potassium (K) channels, Kv1.3 and KCa, which are involved in regulation of Ca flux in 
T cells.  Kv1.3 channels are voltage-gated and activated when the membrane potential 
is depolarized, whereas KCa channels are ac tivated by  i ncreases i n i ntracellular Ca.  
Both channels function to move K ions out of  the cell to increase the dr iving force of  
Ca.  Alterations that prevent the efflux of K ions reduce the Ca driving force resulting in 
a dec rease in i ntracellular Ca.  Using a membrane potential dye we determined that 
DCPA-induced dec reases i n C a i nflux w ere not  m ediated by al terations i n t he 
membrane potential. 
In T cells, CRAC channels are responsible for the Ca influx observed in activated 
cells.  I n T cells from patients with SCID syndrome, Feske et al reported that these T 
cells r etained onl y 1 -2% of  t he normal C a i nflux obs erved i n s timulated c ells (Feske 
2009). U sing el ectrophysiological and  m olecular bi ological m ethods t hey determined 
that this defect was due solely to the absence of functional CRAC channels.  2-APB is 
a w idely u sed m odulator of  C RAC c hannels. Low  c oncentrations (<5 µM ) of 2 -APB 
enhance Ca influx t hrough C RAC c hannels f ollowing s tore depl etion w ithout al tering 
IP3-mediated r elease of  C a from t he E R ( Prakriya and  L ewis 2001 ).  High 




understand t he ef fects of  D CPA i n Ca s ignaling.  We dem onstrate t hat, at C RAC-
enhancing concentrations of  2 -APB ( 2.5µM), we  c ould in hibit Ca  in flux wit h DCPA.   
This c ombined d ata supports our  hy pothesis t hat D CPA alters C a i nflux t hrough 
inhibition of CRAC channels. 
The toxicity of some chlorine compounds has been well documented and toxicity 
is dependent on the number, structure and location of the chlorine(s) (Naumann 2000).  
Vinyl chloride, 1,2 dichloroethane, polychlorinated biphenyls, DDT and h eptachlor are 
common chlorine products with known toxicities.  DCPA is a small lipophilic compound 
with 2 chlorines at the 3 and 4 positions on the benzene ring.  Notably, although DCPA 
is l ipophilic, i t has  r ecently bee n r eported t hat i t bec omes l ocalized i n t he c ytosolic 
fraction of  T c ells a nd hept aocytes ( Hanson, P eer et  al . 2010) . The ef fect of  t he 
chlorines on its toxicity is unknown.  W e report that, substitution of the 2 c hlorines, in 
DCPA and DCA, with fluorines, to produce DFPA and DFA, respectively, resulted in a 
complete r eversal of  al l ef fects.  Thi s c learly es tablishes a m echanism w hereby t he 
presence of t he c hlorines al ters T c ell f unction. S everal pos sibilities e xist f or t he 
differential ef fects obs erved w ith c hlorine and f luorine.  Fi rst, f luorines are hi ghly 
electronegative and  act onl y a s hy drogen ac ceptors w hereas c hlorine and ot her 
halogens act as both hydrogen acceptors and donors (Purser, Moore et al. 2008).  This 
increase in el ectronegativity could al ter t he di stribution of  charge so t hat t he f luorine 
analogs d o not  i nteract w ith i ts t arget i n t he s ame m anner as  D CPA and D CA.  
Second, t rifluoro-substitution has been r eported t o increase lipophilicity but  mono- or 
difluoro-substitution can t o dec rease i t (Purser, Mo ore et al . 20 08).  Changes i n t he 




targeted to the cytosol, increases in l ipophilicity may prevent access into the cytosol.  
Lastly, f luorines ar e s imilar i n s ize t o hy drogen and m ay not  pr oduce t he 3-D 
confirmation r equired t o el icit t he ef fects of  D CPA.  Further s tudies ar e r equired t o 
determine t he m echanism of  D CPA, i n particular, how  t he po sition and location o f 
chlorines alters T cell function. 
Based on the dat a c ollected we hy pothesized t hat the i nhibition of  Ca influx 
observed in T cells exposed to DCPA was due to alterations in CRAC channel activity.  
Only i n r ecent years has i t become possible t o assess changes i n CRAC a ctivity by  
methods other than electrophysiology.  The discovery of two critical proteins in CRAC 
activation, S tim1 and  O rai1, al lows f or a m ore det ailed i nvestigation i nto pos sible 
inhibitors of CRAC channels.  Stim1 is an ER transmembrane protein that aggregates 
into punc ta w hen ER s tores ar e depl eted and i nteracts w ith O rai1 pr oteins i n t he 
plasma membrane to activate CRAC channels.  Puncta formation can be v isualized in 
cells that express YFP-tagged Stim1 and di sruption of the puncta formation results in 
loss of CRAC activity and Ca influx (Liou, Fivaz et al. 2007; Hewavitharana, Deng et al. 
2008).  In the absence of Stim1, mouse CD4+ T cells produce little Ca influx when ER 
stores ar e depleted a nd TC R-stimulated T c ells pr oduce s ignificantly l ess I L-2 (Oh-
Hora, Yamashita et  al. 2008) .  K nockdown of S tim1 in HEK 293 cells al so results i n 
decreased Ca influx and CRAC activity (Roos, DiGregorio et al. 2005). Here we report 
that HEK 293 cells, t reated with DCPA, failed to produce s ignificant puncta formation 
upon ER store depletion.  Some puncta formation does occur in the DCPA-treated cells 
but the puncta rich regions observed in control cells are not observed.  HEK 293 cells 




identify puncta formation so these were chosen for our studies.  Characterization of the 
role of  S tim1 and O rai1 pr oteins i n C RAC c hannel ac tivation has  been  t horoughly 
investigated i n bot h HEK 293  and J urkat T c ells.  I n bot h c ell t ypes, m utational a nd 
overexpression studies reported that Stim1 puncta formation, its interaction with Orai1 
and activation of CRAC channels all occur in a similar manner.  We extend our results 
in HEK 29 3 c ells a nd c onclude t hat D CPA inhibits I L-2, N FAT an d Ca i nflux by  
inhibiting Stim1 pun cta f ormation i n J urkat T c ells.  Loc alization of D CPA t o t he 
cytosolic f raction i n J urkat T c ells s upports t he pos sibility t hat DCPA c an i nteract 
directly with the cytosolic domain of Stim1 to block puncta formation. In the cytosol, the 
C te rminus o f S tim1 contains a CRAC-activating do main ( CAD) t hat, w hen del eted, 
does not form Stim1 puncta (Park, Hoover et al. 2009).  A lthough little is known about 
this domain, it is possible that DCPA could alter this interaction leading to the inhibition 
of S tim1 puncta. However, there are several other possibilities that may a lso explain 
these results.  A reduction in the mobility of the plasma membrane hydrocarbon chains, 
in s timulated J urkat T c ells e xposed t o D CPA, ha s been r eported and  i t m ay be 
possible for this to occur on the ER membrane and possibly inhibit Stim1 dimerization 
(Brundage, B arnett et  al . 2003) .  I nteraction w ith c ytoskeletal proteins c ould a lso 
prevent Stim1 puncta formation.  S ome studies indicate a r ole for the cytoskeleton in 
Stim1 agg regation.  Stim1 can c olocalize w ith alpha-tubulin and  d isruption of 
microtubules w ith n ocodazole r esulted in a diffuse distribution of  Stim1 (Smyth, 
DeHaven et al. 2007).  Sin ce DCPA inhibits Stim1 puncta formation, it seems unlikely 
that D CPA di rectly al ters O rai1 as  aggr egation of  S tim1 i s i ndependent of  Orai1 




occur before Orai1 aggregation.  Fur ther s tudies are required to determine the exact 
nature of DCPA inhibition of Stim1. 
In conclusion, exposure of Jurkat T cells to DCPA and its metabolites alters T cell 
function t hrough i nhibition of  I L-2 and N FAT.  The par ent c ompound, D CPA, and i ts 
metabolite, D CA, bot h i nhibit T c ell f unction by  dec reasing I L-2 s ecretion i n a N FAT 
and C a-dependent m anner.  D CPA ap pears t o be a m ore pot ent i nhibitor of  I L-2 
secretion as greater decreases in IL-2 are observed at lower concentrations of DCPA 
than t hat of D CA.  N OH-DCA a lmost e liminated I L-2 pr oduction but  i n a C a-
independent manner.  The pos itioning and presence o f chlorines on D CPA and D CA 
are critical in eliciting these toxic effects.  Finally, DCPA appears to be a novel inhibitor 
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